<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69975</article-id><article-id pub-id-type="doi">10.7554/eLife.69975</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte β−selection</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-237418"><name><surname>Liu</surname><given-names>Xia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-237419"><name><surname>Yu</surname><given-names>Jingjing</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2408-5809</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-237420"><name><surname>Xu</surname><given-names>Longyong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8574-4062</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-237437"><name><surname>Umphred-Wilson</surname><given-names>Katharine</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6416-0466</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237422"><name><surname>Peng</surname><given-names>Fanglue</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237423"><name><surname>Ding</surname><given-names>Yao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237424"><name><surname>Barton</surname><given-names>Brendan M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237425"><name><surname>Lv</surname><given-names>Xiangdong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237435"><name><surname>Zhao</surname><given-names>Michael Y</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237436"><name><surname>Sun</surname><given-names>Shengyi</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123384"><name><surname>Hong</surname><given-names>Yuning</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53634"><name><surname>Qi</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-237430"><name><surname>Adoro</surname><given-names>Stanley</given-names></name><email>sxa726@case.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-236747"><name><surname>Chen</surname><given-names>Xi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7995-6202</contrib-id><email>xi.chen@bcm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Molecular and Cellular Biology, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Pathology, School of Medicine, Case Western Reserve University</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Center for Molecular Medicine and Genetics, Wayne State University</institution><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Department of Chemistry and Physics, La Trobe University</institution><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff6"><label>6</label><institution>Department of Molecular and Integrative Physiology, University of Michigan Medical School</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name><role>Reviewing Editor</role><aff><institution>University of Toronto, Sunnybrook Research Institute</institution><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>09</day><month>07</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69975</elocation-id><history><date date-type="received" iso-8601-date="2021-05-03"><day>03</day><month>05</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-07-05"><day>05</day><month>07</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-05-07"><day>07</day><month>05</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.05.06.443041"/></event></pub-history><permissions><copyright-statement>© 2021, Liu et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Liu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69975-v3.pdf"/><abstract><p>Signals from the pre-T cell receptor and Notch coordinately instruct β-selection of CD4<sup>–</sup>CD8<sup>–</sup>double negative (DN) thymocytes to generate αβ T cells in the thymus. However, how these signals ensure a high-fidelity proteome and safeguard the clonal diversification of the pre-selection TCR repertoire given the considerable translational activity imposed by β-selection is largely unknown. Here, we identify the endoplasmic reticulum (ER)-associated degradation (ERAD) machinery as a critical proteostasis checkpoint during β-selection. Expression of the SEL1L-HRD1 complex, the most conserved branch of ERAD, is directly regulated by the transcriptional activity of the Notch intracellular domain. Deletion of <italic>Sel1l</italic> impaired DN3 to DN4 thymocyte transition and severely impaired mouse αβ T cell development. Mechanistically, <italic>Sel1l</italic> deficiency induced unresolved ER stress that triggered thymocyte apoptosis through the PERK pathway. Accordingly, genetically inactivating PERK rescued T cell development from <italic>Sel1l</italic>-deficient thymocytes. In contrast, IRE1α/XBP1 pathway was induced as a compensatory adaptation to alleviate <italic>Sel1l</italic>-deficiency-induced ER stress. Dual loss of <italic>Sel1l</italic> and <italic>Xbp1</italic> markedly exacerbated the thymic defect. Our study reveals a critical developmental signal controlled proteostasis mechanism that enforces T cell development to ensure a healthy adaptive immunity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>thymocytes</kwd><kwd>proteostasis</kwd><kwd>beta-selection</kwd><kwd>ER-associated degradation</kwd><kwd>ER stress</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01HL146642</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Xi</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01 AI1143992</award-id><principal-award-recipient><name><surname>Adoro</surname><given-names>Stanley</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R37CA228304</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Xi</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>K22CA218467</award-id><principal-award-recipient><name><surname>Adoro</surname><given-names>Stanley</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P50CA186784</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Xi</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM130292</award-id><principal-award-recipient><name><surname>Qi</surname><given-names>Ling</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014042</institution-id><institution>DOD Peer Reviewed Cancer Research Program</institution></institution-wrap></funding-source><award-id>W81XWH1910524</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Xi</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014042</institution-id><institution>DOD Peer Reviewed Cancer Research Program</institution></institution-wrap></funding-source><award-id>W81XWH1910306</award-id><principal-award-recipient><name><surname>Adoro</surname><given-names>Stanley</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000090</institution-id><institution>Congressionally Directed Medical Research Programs</institution></institution-wrap></funding-source><award-id>W81XWH1910035</award-id><principal-award-recipient><name><surname>Lv</surname><given-names>Xiangdong</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004917</institution-id><institution>Cancer Prevention and Research Institute of Texas</institution></institution-wrap></funding-source><award-id>RP160283</award-id><principal-award-recipient><name><surname>Peng</surname><given-names>Fanglue</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Endoplasmic reticulum-associated degradation (ERAD) is a critical protein quality control checkpoint for thymocyte β-slection.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>T cells develop from bone-marrow-derived early T-cell progenitors (ETP) through a series of well-orchestrated proliferation and differentiation steps in the thymus. In response to intrathymic interleukin (IL)−7 and Kit ligand, ETPs proliferate and differentiate into CD4<sup>-</sup>CD8<sup>-</sup>double negative (DN) thymocytes (<xref ref-type="bibr" rid="bib58">von Freeden-Jeffry et al., 1997</xref>). Subsequent differentiation of DN thymocytes into CD4<sup>+</sup>CD8<sup>+</sup> (double positive, DP) thymocytes depends on whether DN3 stage (CD44<sup>-</sup>CD25<sup>+</sup>) thymocytes successfully undergo ‘β-selection’, the first major checkpoint during αβ T cell development (<xref ref-type="bibr" rid="bib48">Shah and Zúñiga-Pflücker, 2014</xref>). β-selection is initiated by signals from the pre-TCR (a heterodimer of the invariant pre-Tα and TCRβ proteins) in DN3 thymocytes that have productively undergone V(D)J recombination at the <italic>Tcrb</italic> locus (<xref ref-type="bibr" rid="bib37">Mallick et al., 1993</xref>; <xref ref-type="bibr" rid="bib39">Michie and Zúñiga-Pflücker, 2002</xref>). In addition to cell autonomous signal through the pre-TCR, β-selection also requires signal from the Notch receptor (<xref ref-type="bibr" rid="bib15">Ciofani and Zúñiga-Pflücker, 2005</xref>; <xref ref-type="bibr" rid="bib46">Sambandam et al., 2005</xref>). Coordinately, pre-TCR and Notch signals induce DN3 thymocytes to undergo 100–200 fold clonal expansion (<xref ref-type="bibr" rid="bib64">Yamasaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib67">Zhao et al., 2019</xref>) as they differentiate into DN4 (CD44<sup>-</sup>CD25<sup>-</sup>) cells which give rise to the DP thymocyte precursors of mature αβ T cells. This proliferative burst is crucial for the diversification of the pre-selection TCR repertoire (<xref ref-type="bibr" rid="bib35">Kreslavsky et al., 2012</xref>) and so must be robustly buffered to ensure adequate number of thymocytes audition for positive selection. β-selection imposes a considerable demand for new protein synthesis of the newly rearranged <italic>Tcrb</italic> gene and the multiple factors that execute the transcriptional and metabolic programs demanded by DN thymocyte proliferation. However, how proteome homeostasis or ‘proteostasis’ is regulated during thymocyte development is largely unknown.</p><p>Endoplasmic reticulum (ER) is the major subcellular site for synthesis and maturation of all transmembrane and secreted proteins. Protein folding is an inherently error-prone process and is tightly regulated by a myriad of chaperones and enzymes (<xref ref-type="bibr" rid="bib3">Balchin et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Cox et al., 2020</xref>). To maintain proteostasis and normal cell function, cells have evolved highly sensitive and sophisticated quality control systems to ensure the fidelity of protein structure, which is especially important for thymocytes undergoing β-selection that must repair protein damage and generate a functional and diverse repertoire of T cell receptors with high fidelity (<xref ref-type="bibr" rid="bib20">Feige et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Feige and Hendershot, 2013</xref>). Two such systems conserved across different species are ER-associated degradation (ERAD) and the unfolded protein response (UPR) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib7">Brodsky, 2012</xref>; <xref ref-type="bibr" rid="bib29">Hwang and Qi, 2018</xref>; <xref ref-type="bibr" rid="bib59">Walter and Ron, 2011</xref>). ERAD is the principal protein quality control mechanism responsible for targeting misfolded proteins in the ER for cytosolic proteasomal degradation. The E3 ubiquitin ligase HRD1 and its adaptor protein SEL1L, constitute the most conserved branch of ERAD (<xref ref-type="bibr" rid="bib7">Brodsky, 2012</xref>; <xref ref-type="bibr" rid="bib43">Qi et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Ruggiano et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Sun et al., 2014</xref>). SEL1L recruits misfolded proteins bound by ER protein chaperones to the SEL1L-HRD1 complex, through which the misfolded proteins are retrotranslocated into cytosol, ubiquitinated and degraded by the proteasome in the cytosol with the help of CDC48/ p97 (<xref ref-type="bibr" rid="bib7">Brodsky, 2012</xref>; <xref ref-type="bibr" rid="bib41">Nakatsukasa and Brodsky, 2008</xref>). Failure to clear the misfolded proteins in the ER activates the UPR (<xref ref-type="bibr" rid="bib7">Brodsky, 2012</xref>; <xref ref-type="bibr" rid="bib29">Hwang and Qi, 2018</xref>; <xref ref-type="bibr" rid="bib45">Ruggiano et al., 2014</xref>). The UPR is a highly conserved, three-pronged pathway that is activated when the rate of cellular protein production exceeds the capacity of the ER to correctly fold and process its protein load or by various intracellular and extracellular stressors that interfere with the protein folding process. This coordinated response is mediated by three ER-localized transmembrane sensors: IRE1α, ATF6α, and PERK (<xref ref-type="bibr" rid="bib25">Hetz et al., 2011</xref>). Under ER stress, IRE1α undergoes oligomerization and <italic>trans</italic>-autophosphorylation to activate its RNase domain to induce unconventional splicing of its substrate XBP1 (<xref ref-type="bibr" rid="bib29">Hwang and Qi, 2018</xref>; <xref ref-type="bibr" rid="bib59">Walter and Ron, 2011</xref>). ER stress also induces PERK-dependent eIF2α phosphorylation and subsequent increased cap-independent translation of ATF4 and induction of CHOP (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib29">Hwang and Qi, 2018</xref>; <xref ref-type="bibr" rid="bib59">Walter and Ron, 2011</xref>).</p><p>Here, we show that ERAD is the master regulator of physiological ER proteostasis in immature DN thymocytes. The ERAD machinery was critically required for successful β-selection of DN3 thymocytes and consequently, ERAD deficiency impeded αβ T cell development. Intriguingly, ERAD selectively preserves the cellular fitness of αβ, but not γδ T lymphocytes. We found that Notch signaling directly regulates ERAD gene expression to promote the integrity of ER proteostasis during β-selection. Activation of ERAD restricts PERK-dependent cell death in DN3 thymocytes during β-selection. Genetic inactivation of <italic>Perk</italic> rescued β-selection in <italic>Sel1l</italic>-deficient thymocytes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Stringent protein quality control in β-selected thymocytes</title><p>To determine translational dynamics in developing thymocytes, we injected wildtype C57BL/6 (WT) mice with O-propargyl puromycin (OP-Puro), a cell-permeable puromycin analog that is incorporated into newly synthesized proteins as a measure of protein synthesis rates (<xref ref-type="bibr" rid="bib27">Hidalgo San Jose and Signer, 2019</xref>; <xref ref-type="bibr" rid="bib55">Tong et al., 2020</xref>). Animals were euthanized 1 hr after OP-Puro injection, and thymocyte subsets (gated as shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B,C</xref>) were assessed by flow cytometry for OP-Puro incorporation (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Compared to DP and mature single positive thymocytes, DN2 to DN4 thymocytes incorporated the most OP-Puro (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), a likely reflection of their high metabolic and proliferative activity (<xref ref-type="bibr" rid="bib10">Carpenter and Bosselut, 2010</xref>; <xref ref-type="bibr" rid="bib35">Kreslavsky et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Nagelreiter et al., 2018</xref>). To assess the relationship between translational activity and proteome quality, we stained WT thymocytes with tetraphenylethene maleimide (TMI), a cell-permeable reagent that only fluoresces when bound to free thiol groups typically exposed on misfolded or unfolded proteins (<xref ref-type="bibr" rid="bib12">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Hidalgo San Jose et al., 2020</xref>). Intriguingly, despite comparable and high protein synthesis rates across DN2 to DN4 thymocytes, we found that DN4 thymocytes displayed markedly lower levels of misfolded/unfolded proteins (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). These observations suggested that the DN3-to-DN4 transition, which is initiated by β-selection, is accompanied by induction of proteome quality control mechanisms.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Protein quality control in β-selected thymocytes.</title><p>(<bold>A</bold>) Schematic of labeling and detection of nascent protein with OP-Puro. OP-Puro (O-propargyl puromycin) is a cell-permeable puromycin analog that is incorporated into the C-terminus of newly synthesized peptide chain. Fluorophore conjugated with Alexa Fluor 647 was then attached to OP-Puro through a copper-catalyzed click chemistry reaction between alkyne and azide group, which quantifies protein synthesis by fluorescence intensity. (<bold>B</bold>) Representative histogram (left) and quantification (right) of OP-Puro incorporation in different thymocyte subsets from 8-week-old wild-type mice. FMO represents AF647 control which is the background from the click chemistry in the absence of OP-Puro. MFI, mean fluorescence intensity. <italic>n</italic> = four mice. (<bold>C</bold>) Quantification of tetraphenylethene maleimide (TMI) fluorescence in different thymocyte subsets from 8-week-old wild-type mice. <italic>n</italic> = seven mice. (<bold>D</bold>) Quantitative RT-PCR analysis of ERAD (<italic>Sel1l</italic>) and UPR-related (<italic>Xbp1</italic>, <italic>Hspa5(Bip)</italic>, <italic>Dnajb9</italic>, <italic>Ddit3</italic> (<italic>Chop</italic>), <italic>Atf4</italic>) genes expression in different thymocyte subsets from 6-week-old wild-type mice. Data are presented relative to <italic>Actb; n</italic> = three mice. (<bold>B–D</bold>), ETP: early T lineage precursor (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>+</sup> CD25<sup>-</sup> CD117<sup>+</sup>); DN2: double negative two thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>+</sup> CD25<sup>+</sup>); DN3: double negative three thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>-</sup> CD25<sup>+</sup>); DN4: double negative four thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>-</sup> CD25<sup>-</sup>); DP: double positive thymocytes (Lin<sup>-</sup> CD4<sup>+</sup> CD8<sup>+</sup>); SP4: CD4 single positive thymocytes (Lin<sup>-</sup> CD4<sup>+</sup> CD8<sup>-</sup>); SP8: CD8 single positive thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>+</sup>). Results are shown as mean ± s.d. The statistical signiﬁcance was calculated by one-way ANOVA with Bonferroni test. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, n.s., not signiﬁcant.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Diagrams and representative flow cytometry gates used in this study.</title><p>(<bold>A</bold>) Diagram showing two ER quality control machineries: ERAD and UPR. The E3 ubiquitin ligase HRD1 and its adaptor protein SEL1L is the most conserved ERAD complex in mammals. While correctly folded proteins exit the ER, misfolded proteins in the ER are recruited to the SEL1L-HRD1 complex through ER chaperones (such as BiP, EDEM, and OS9), and then retrotranslocated into the cytosol, ubiquitinated and degraded by the proteasome. Failure to clear the misfolded or unfolded proteins in the ER activates the UPR signaling through three ER stress sensors IRE1α, ATF6, and PERK. Upon activation, IRE1α oligomerizes and undergoes <italic>trans</italic>-autophosphorylation to activate its RNase domain, resulting in the removal of 26 nucleotides from unspliced <italic>XBP1</italic> (<italic>XBP1u</italic>) mRNA to produce mature, spliced <italic>XBP1</italic> (<italic>XBP1s</italic>) mRNA. PERK is a serine-threonine kinase. ER stress induces PERK-dependent eIF2α phosphorylation and subsequent increased cap-independent translation of ATF4 and induction of CHOP. (<bold>B</bold>) Schematic diagram of T-cell development in the thymus. CLP: common lymphoid progenitors; ETP: early T lineage precursor (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>+</sup> CD25<sup>-</sup> CD117<sup>+</sup>); DN2: double negative two thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>+</sup> CD25<sup>+</sup>); DN3: double negative three thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>-</sup> CD25<sup>+</sup>); DN4: double negative four thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>-</sup> CD44<sup>-</sup> CD25<sup>-</sup>); ISP: immature single-positive thymocytes (Lin<sup>-</sup>CD8<sup>+</sup>CD24<sup>+</sup>TCRβ<sup>-</sup>); DP: double positive thymocytes (Lin<sup>-</sup> CD4<sup>+</sup> CD8<sup>+</sup>); SP4: CD4 single positive thymocytes (Lin<sup>-</sup> CD4<sup>+</sup> CD8<sup>-</sup>); SP8: CD8 single positive thymocytes (Lin<sup>-</sup> CD4<sup>-</sup> CD8<sup>+</sup>). (<bold>C</bold>) Representative pseudocolor plots showing the gating strategy to identify different thymocyte subsets in the thymus.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig1-figsupp1-v3.tif"/></fig></fig-group><p>To understand the protein quality control mechanisms operating in thymocytes, we performed quantitative PCR to determine expression of genes encoding ER protein quality control machinery. We found elevated expression of the core ERAD (<italic>Sel1l</italic>) and the UPR (<italic>Xbp1</italic>, <italic>Ddit3 (Chop), Atf4, Dnajb9,</italic> and <italic>Hspa5</italic> (<italic>Bip</italic>)) genes in DN3 thymocytes (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Notably, induction of these genes peaked in the DN3 thymocyte stage in which β-selection is initiated (<xref ref-type="bibr" rid="bib53">Takahama, 2006</xref>) and preceded the reduction of misfolded/unfolded proteins in DN4 cells. These results prompted us to hypothesize and explore whether β-selection signals induce proteome quality control mechanisms in DN3 cells to enable subsequent stages of thymocyte development.</p></sec><sec id="s2-2"><title>The ERAD machinery is required for αβ T cell development</title><p>To resolve the ER proteostasis machinery required for the development of thymocytes, we conditionally deleted individual genes encoding key mediators of the UPR (<italic>Xbp1</italic>, <italic>Perk</italic>) and ERAD (<italic>Sel1l</italic>) using the h<italic>CD2</italic>-iCre transgene (<xref ref-type="bibr" rid="bib51">Siegemund et al., 2015</xref>). In this model, significant Cre activity initiated in ETP thymocytes (<xref ref-type="bibr" rid="bib50">Shi and Petrie, 2012</xref>; <xref ref-type="bibr" rid="bib51">Siegemund et al., 2015</xref>) and was efficient in depleting genes in subsequent stages of thymocyte development and mature T cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A,B</xref>). Deletion of the UPR mediator <italic>Xbp1</italic> or <italic>Perk</italic> had no effect on T cell development as thymic cellularity, numbers of DN, DP, single positive (SP) thymocytes and splenic T cell numbers were comparable in gene-deficient and littermate control animals (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–J</xref>). Similarly, <italic>Vav1-</italic>iCre<italic>-</italic>mediated deletion of <italic>Atf6a</italic> which initiates in bone marrow hematopoietic cell progenitors (<xref ref-type="bibr" rid="bib32">Joseph et al., 2013</xref>) did not perturb thymocyte development (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1K–N</xref>).</p><p>Strikingly, <italic>CD2</italic>-iCre-mediated deletion of the ERAD core component <italic>Sel1l (Sel1l<sup>flox/flox</sup>;</italic> CD2-iCre mice, hereafter designated as <italic>Sel1l</italic> CKO) resulted in a markedly decreased thymus size and cellularity, with significantly reduced and dispersed medullary regions compared to control littermates (<italic>Sel1l<sup>flox/flox</sup></italic>; Ctrl) (<xref ref-type="fig" rid="fig2">Figure 2A–D</xref>). The reduced thymus cellularity was accompanied by a profound reduction of peripheral T cells in the spleen and lymph nodes from <italic>Sel1l</italic> CKO mice compared to control animal (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1O–R</xref>). <italic>Sel1l</italic> deletion had no impact on γδ T cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1S</xref>), indicating that within the T-cell lineage, SEL1L is selectively required for αβ T cell development.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>SEL1L is required for αβ T cell development.</title><p>(<bold>A</bold>) Images of thymus from 6 to 8 week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n =</italic> 3. (<bold>B and C</bold>) Thymus weight (<bold>B</bold>) and thymus cellularity (<bold>C</bold>) of age and gender-matched control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 4. (<bold>D</bold>) Representative images of H and E staining of thymus from 6~8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. Scale bars are indicated. C: Cortex. M: Medulla. (<bold>E and F</bold>) Quantification of cell numbers of the indicated thymocyte subsets in 6- to 8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n =</italic> 4. (<bold>G</bold>) Schematic depiction of the competitive bone marrow transplantation (BMT) experiment using whole bone marrow cells from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice as donors. (<bold>H and I</bold>) Representative flow cytometry plots (<bold>H</bold>) and percentage (<bold>I</bold>) of control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO donor-derived thymocyte subsets in the recipient mice 14 weeks after transplantation. <italic>n</italic> = 4–5. (<bold>J</bold>), Schematic overview of OP9-DL1 cell co-culture system. Sorted DN2 or DN3 cells from control (Ctrl) or <italic>Sel1l</italic> CKO mice were cultured on a monolayer of OP9 -DL1 cells supplemented with IL-7 and Flt3. (<bold>K, L, M</bold>) Representative pseudocolor plots (<bold>K</bold>) and percentage of DN3 (<bold>L</bold>) or DN4 (<bold>M</bold>) in DN thymocytes at indicated time points after in vitro co-culture of equal number of control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO DN2 cells on OP9-DL1 cells supplemented with IL-7 and Flt3. <italic>n =</italic> 3. Results are shown as mean ± s.d. The statistical signiﬁcance was calculated by two-tailed unpaired t-test (<bold>B, C, E, F, I</bold>) or two-way ANOVA with Bonferroni test (<bold>L, M</bold>). *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, n.s., not signiﬁcant.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>UPR is dispensable for αβ T cell development.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of <italic>Sel1l</italic> expression in murine bone marrow progenitors and different thymocyte subsets from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. Data are presented relative to <italic>Actb. n</italic> = 4. LMPP: lymphoid-primed multipotent progenitor. (<bold>B</bold>) Western blot analysis of SEL1L protein in sorted DN3 and DN4 thymocytes from Ctrl or <italic>Sel1l</italic> CKO mice. β-ACTIN was used as loading control. The original western blot images are provided in <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>. (<bold>C–F</bold>) Representative images of thymus (<bold>C</bold>), thymus cellularity (<bold>D</bold>), cell numbers of indicated populations in the thymus (<bold>E</bold>) and peripheral splenocyte numbers of indicated populations (<bold>F</bold>) from age and gender-matched control (Ctrl, <italic>Perk<sup>flox/flox</sup></italic>) or <italic>Perk</italic> CKO (<italic>Perk<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 4. (<bold>G–J</bold>) Representative images of thymus (<bold>G</bold>), thymus cellularity (<bold>H</bold>), cell numbers of indicated populations in the thymus (<bold>I</bold>) and peripheral splenocyte numbers of indicated populations (<bold>J</bold>) from age and gender-matched control (Ctrl, <italic>Xbp1<sup>flox/flox</sup></italic>) or <italic>Xbp1</italic> CKO (<italic>Xbp1<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 3–4. (<bold>K–N</bold>) Representative images of thymus (<bold>K</bold>), thymus cellularity (<bold>L</bold>), cell numbers of indicated populations in the thymus (<bold>M</bold>) and peripheral splenocyte numbers of indicated populations (<bold>N</bold>) from age and gender-matched control (Ctrl, <italic>Atf6<sup>flox/flox</sup></italic>) and <italic>Atf6<sup>flox/flox</sup>; Vav1-</italic>iCre mice. <italic>n</italic> = 5. (<bold>O</bold>) Images of spleen from 6 to 8 week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. (<bold>P</bold>) Quantification of cell numbers of the indicated populations in the spleen of 6- to 8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. (<bold>Q</bold>) Images of the inguinal (left) lymph nodes from 6- to 8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. (<bold>R</bold>) Quantification of cell numbers in the lymph nodes of 6- to 8 week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 4. (<bold>S</bold>) Quantification of cell numbers of γδ T cells from 6- to 8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. Ctrl: <italic>n =</italic> 4. <italic>Sel1l</italic> CKO: <italic>n =</italic> 5. Data are representative of three independent experiments and are shown as mean ± s.d. Two-tailed Student’s t-tests (<bold>A, D–F, H–J, L–N, P, R, S</bold>) was used to calculate p values. n.s., not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Original western blot images shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig2-figsupp1-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig2-figsupp1-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig2-figsupp1-v3.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>SEL1L is required for DN to DP thymocyte transition following β selection.</title><p>(<bold>A</bold>) Representative flow cytometry plots of different thymocyte subsets in control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. (<bold>B</bold>) Diagram showing different stages of <italic>CD2</italic>-iCre and <italic>Cd4-Cre</italic> initiated gene depletion during T cell development. (<bold>C</bold>) Quantitative RT-PCR analysis of <italic>Sel1l</italic> in different thymocyte subsets from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l<sup>flox/flox</sup>; Cd4-</italic>Cre mice. Data are presented relative to <italic>Actb. n</italic> = 3. (<bold>D and E</bold>) Representative images of thymus (<bold>D</bold>) and quantification of thymus cellularity (<bold>E</bold>) in 6- to 8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l<sup>flox/flox</sup>; Cd4-</italic>Cre mice. <italic>n</italic> = 3. (<bold>F and G</bold>) Quantification of cell numbers of different thymocyte subsets from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l<sup>flox/flox</sup>; Cd4</italic>-Cre mice. <italic>n =</italic> 3. (<bold>H</bold>) Percentage of Ctrl or <italic>Sel1l</italic> CKO donor-derived progenitors in the bone marrow of recipient mice 14 weeks after transplantation. <italic>n</italic> = 4–5. (<bold>I</bold>) Quantification of Ctrl or <italic>Sel1l</italic> CKO donor-derived DN3/DN4 ratio. <italic>n =</italic> 4–5. (<bold>J</bold>) Percentage of Ctrl or <italic>Sel1l</italic> CKO donor-derived CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells, myeloid cells, and dendritic cells (DC) in the spleen of recipient mice 14 weeks after transplantation. <italic>n</italic> = 4–5. (<bold>K and L</bold>) Cell cycle analysis of DN3 thymocytes in 6-week-old control (Ctrl) and <italic>Sel1l</italic> CKO mice using Ki67 and DAPI. Representative flow cytometry plots (<bold>K</bold>) and quantification (<bold>L</bold>) are shown. <italic>n</italic> = 3. Data are shown as mean ± s.d. The statistical signiﬁcance was calculated by two-tailed unpaired t-test (<bold>C, E-J</bold>) or Two-way ANOVA with Bonferroni test (<bold>L</bold>). n.s., not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig2-figsupp2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig2-figsupp2-v3.tif"/></fig></fig-group></sec><sec id="s2-3"><title>SEL1L is required for DN to DP thymocyte transition following β selection</title><p>While <italic>Sel1l</italic> CKO mice had similar numbers of DN thymocytes (<xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>), they showed significantly reduced numbers of DP and mature SP thymocytes compared to littermate controls (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). This finding suggests that SEL1L functioned during the DN to DP thymocyte transition. To clarify this possibility, we generated and analyzed thymocyte developmental stages in <italic>Sel1l<sup>flox/flox</sup>; Cd4-</italic>Cre mice. Unlike <italic>CD2</italic>-iCre which initiated in ETP (<xref ref-type="bibr" rid="bib51">Siegemund et al., 2015</xref>), <italic>Cd4</italic>-Cre initiated in immature single-positive (ISP, CD8<sup>+</sup>CD24<sup>+</sup>TCRβ<sup>-</sup>) thymocytes (<xref ref-type="bibr" rid="bib24">Gegonne et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Kadakia et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Xu et al., 2016</xref>) and only significantly depleted <italic>Sel1l</italic> in ISPs and later stage thymocytes (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B,C</xref>). <italic>Sel1l<sup>flox/flox</sup>; Cd4-</italic>Cre mice exhibited indistinguishable thymic cellularity, immature DN, DP and SP thymocytes numbers from control mice (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D–G</xref>). Thus, whereas SEL1L is dispensable for differentiation of post-DN4 thymocytes (i.e. DP, SP, and mature T cells), its expression is critical for DN to DP thymocyte differentiation.</p><p>To delineate the DN thymocyte developmental stage at which SEL1L is required, we generated 1:1 mixed bone marrow (BM) chimeras by transplanting equal numbers of whole BM cells from control (<italic>Sel1l<sup>flox/flox</sup></italic>, CD45.2<sup>+</sup>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre, CD45.2<sup>+</sup>) mice along with congenic (CD45.1<sup>+</sup>) wild-type (WT) competitor BM cells into irradiated CD45.1<sup>+</sup> recipient mice (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Fourteen weeks after transplantation, control and <italic>Sel1l</italic> CKO donors reconstituted similar numbers of all BM hematopoietic progenitors including Lineage<sup>-</sup>Sca-1<sup>+</sup>c-Kit<sup>+</sup> (LSK) cells, hematopoietic stem progenitor cells (HSPC), multipotent progenitor (MPP), and myeloid progenitors (Lineage<sup>-</sup>Sca-1<sup>-</sup>c-Kit<sup>+</sup>LS-K) cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2H</xref>). We found substantial defective thymus reconstitution starting from the DN4 stage from <italic>Sel1l</italic>-CKO donors (<xref ref-type="fig" rid="fig2">Figure 2H,I</xref>). <italic>Sel1l</italic> CKO-donor-derived DN3 to DN4 ratio was significantly increased compared to controls (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2I</xref>), suggesting that <italic>Sel1l</italic> depletion compromised the fitness of DN3 thymocytes in which β-selection occurs and impaired their transition to the DN4 stage. The impaired DN thymus reconstitution from <italic>Sel1l</italic> CKO donors was accompanied by severe defects in subsequent donor-derived DP and SP thymocytes (<xref ref-type="fig" rid="fig2">Figure 2H,I</xref>), as well as peripheral T cells in the spleen (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2J</xref>). These data demonstrate a cell-intrinsic requirement of <italic>Sel1l</italic> for DN3 thymocyte progression to later stages of thymocyte differentiation. <italic>Sel1l</italic> deletion also caused significant B cell reconstitution defects (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2J</xref>), consistent with previous publications showing that SEL1L/HRD1 ERAD is required for B cell development through regulating pre-BCR (<xref ref-type="bibr" rid="bib31">Ji et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Yang et al., 2018</xref>).</p><p>To further clarify the requirement for SEL1L in DN3-to-DN4 thymocyte transition during β-selection, we used the in vitro T cell differentiation system of culturing immature thymocytes on monolayers of OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1 cells) supplemented with IL-7 and Flt3 ligand (<xref ref-type="bibr" rid="bib4">Balciunaite et al., 2005</xref>; <xref ref-type="bibr" rid="bib28">Holmes and Zúñiga-Pflücker, 2009</xref>; <xref ref-type="bibr" rid="bib47">Schmitt et al., 2004</xref>; <xref ref-type="fig" rid="fig2">Figure 2J</xref>). We cultured DN2 thymocytes from control or <italic>Sel1l</italic> CKO mice on OP9-DL1 cells and found that <italic>Sel1l</italic>-deficiency markedly abrogated DN4 thymocyte generation (<xref ref-type="fig" rid="fig2">Figure 2K–M</xref>). On day 17 of co-culture, only 31.3% DN3 cells remained in control-derived cells, while more than three-fold DN3 cells (71.6%) were found in <italic>Sel1l</italic> CKO-derived cells (<xref ref-type="fig" rid="fig2">Figure 2K–M</xref>), consistent with a block in DN3 to DN4 thymocyte transition. Since only DN3 thymocytes that have successfully undergone β-selection differentiate to the DN4 and DP thymocyte stage, these results reinforce that cell-intrinsic SEL1L activity is required for post β-selection DN thymocyte development.</p></sec><sec id="s2-4"><title>SEL1L is required for thymocyte survival at the β-selection checkpoint</title><p>Next, we assessed the impact of <italic>Sel1l</italic> deletion on DN thymocyte proliferation and survival, two key outcomes of successful β-selection (<xref ref-type="bibr" rid="bib15">Ciofani and Zúñiga-Pflücker, 2005</xref>; <xref ref-type="bibr" rid="bib35">Kreslavsky et al., 2012</xref>). Although BrdU incorporation was similar in control and <italic>Sel1l</italic> CKO DN3 thymocytes, we observed more BrdU incorporation in <italic>Sel1l</italic> CKO DN4 thymocytes than that in control DN4 thymocytes (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In agreement, co-staining for Ki-67 and the DNA dye (DAPI) revealed less <italic>Sel1l</italic> CKO DN4 thymocytes in G0 phase, and more in G1 and S/G2/M phase (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>). <italic>Sel1l</italic> CKO DN3 cells showed similar cell cycle kinetics as control DN3 thymocytes, in line with their normal levels of BrdU incorporation (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2K,L</xref>). The higher proliferation of endogenous <italic>Sel1l</italic>-deficient DN4 thymocytes may be a compensation for their compromised fitness. This likely explains the paradoxical observation that <italic>Sel1l</italic> CKO donors generated markedly reduced DN4 thymocytes in BM chimeras (<xref ref-type="fig" rid="fig2">Figure 2H,I</xref>), yet <italic>Sel1l</italic> CKO mice had comparable DN4 thymocytes as control mice in steady state (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>SEL1L is required for thymocyte survival at the β-selection checkpoint.</title><p>(<bold>A</bold>) Quantification of BrdU incorporation in different thymocyte subsets from 6-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO mice. <italic>n =</italic> 3–4. (<bold>B and C</bold>) Cell cycle analysis of DN4 thymocytes in 6-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) using Ki67 and DAPI. Representative flow cytometry plots (<bold>B</bold>) and quantification (<bold>C</bold>) are shown. <italic>n =</italic> 3. (<bold>D</bold>) Quantification of apoptotic Ctrl or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) DN3 thymocytes co-cultured with OP9-DL1 cells in vitro for 2 days. <italic>n</italic> = 3. (<bold>E and F</bold>) Representative images (<bold>E</bold>) and quantification (<bold>F</bold>) of cleaved caspase-3 (CC3) positive cells in the thymus of 6- to 8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. Sixteen fields were counted at ×20 magnification from 4 Ctrl or <italic>Sel1l</italic> CKO mice. Scale bars are indicated. (<bold>G and H</bold>) Representative images (<bold>G</bold>) and quantification (<bold>H</bold>) of TUNEL positive cells in the thymus of 6- to 8-week-old control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n =</italic> 4. Scale bar, 20 μM. Results are shown as mean ± s.d. The statistical signiﬁcance was calculated by two-tailed unpaired t-test (<bold>D, F, H</bold>) or two-way ANOVA with Bonferroni test (<bold>A, C</bold>). *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, n.s., not signiﬁcant.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig3-v3.tif"/></fig><p>That, despite their higher proliferative status, <italic>Sel1l</italic> CKO DN4 thymocytes failed to progress to DP thymocytes and generate mature T-cells prompted us to ask if <italic>Sel1l</italic> deficiency resulted in apoptosis of β-selected thymocytes. To test this possibility, we cultured equal number of DN3 thymocytes from control or <italic>Sel1l</italic> CKO mice on OP9-DL1 stromal cells and assessed their apoptosis in vitro. Indeed, <italic>Sel1l</italic> CKO DN3 thymocytes showed higher apoptosis measured by proportions of Annexin-V positive cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). To confirm that <italic>Sel1l</italic>-deficiency resulted in DN thymocyte apoptosis in vivo, we histologically enumerated apoptosis in thymic sections by measuring active Caspase-3 which degrades multiple cellular proteins and is responsible for morphological changes and DNA fragmentation in cells during apoptosis (<xref ref-type="bibr" rid="bib2">Bai et al., 2013</xref>). Compared to controls, <italic>Sel1l</italic> CKO thymus showed more active Caspase-3 apoptotic cells in the cortex area (<xref ref-type="fig" rid="fig3">Figure 3E,F</xref>), which is typically populated by DN thymocytes (<xref ref-type="bibr" rid="bib56">Trampont et al., 2010</xref>). This observation was further confirmed using TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining (<xref ref-type="fig" rid="fig3">Figure 3G,H</xref>). Taken together, we concluded that <italic>Sel1l-</italic>deficient β-selected DN3 cells were undergoing apoptosis as they differentiated into DN4 thymocytes.</p></sec><sec id="s2-5"><title>Notch directly regulates transcription of ERAD genes</title><p>Having established that the SEL1L-ERAD is a crucial proteostasis machinery required for β-selection, we next sought to understand the thymic signals which regulate <italic>Sel1l</italic> expression in DN thymocytes. Because high <italic>Sell1l</italic> expression (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) coincided with high levels of Notch1 in DN2 and DN3 thymocytes (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), we explored the possibility that Notch ligands might activate the ERAD machinery to enable DN thymocytes to maintain proteostasis during β-selection. Stimulation of the thymoma cell line EL4 with Notch ligand Delta-like 4 (DLL4) (<xref ref-type="bibr" rid="bib9">Camelo et al., 2012</xref>; <xref ref-type="bibr" rid="bib22">Fitzgerald and Greenwald, 1995</xref>) induced expression of the genes involved in ERAD including <italic>Sel1l</italic>, <italic>Hrd1</italic>, <italic>Os9,</italic> and <italic>Edem1</italic> as well as SEL1L proteins (<xref ref-type="fig" rid="fig4">Figure 4B,C</xref>). Induction of these genes by DLL4 was concomitant with the induction of classical Notch targets like <italic>Hes1</italic>, <italic>Deltex1,</italic> and <italic>Ptcra</italic> (pre-Tα) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Notch directly regulates transcription of ERAD genes.</title><p>(<bold>A</bold>) Quantification of surface NOTCH1 levels in different thymocyte subsets from wild-type mice. MFI, mean fluorescence intensity. <italic>n =</italic> four mice. (<bold>B</bold>) Quantitative RT–PCR analysis of ERAD genes (<italic>Sel1l</italic>, <italic>Hrd1</italic>, <italic>Os9</italic>, <italic>Edem1</italic>) expression in EL4 cells after stimulation with 5 μg/ml Delta ligand 4 (DLL4) for 24 hr. Data are presented relative to <italic>Actb. n =</italic> 3. (<bold>C</bold>) Western blot analysis of SEL1L level in EL4 cells after stimulation with Delta ligand 4 (DLL4) for 12 hr. β-ACTIN was used as loading control. The original western blot images are provided in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>. (<bold>D</bold>) Quantitative RT–PCR analysis of ERAD genes (<italic>Sel1l</italic>, <italic>Hrd1</italic>, <italic>Os9</italic>, <italic>Edem1</italic>) expression in primary DN3 thymocytes treated with 2 μM γ-secretase inhibitor DAPT for 5 hr. Data are presented relative to <italic>Actb. n =</italic> 3. (<bold>E</bold>) Conserved RBP-J binding motif (Red) within the promoters of <italic>Sel1l</italic> and <italic>Hrd1</italic>. Alignment of the <italic>Sel1l</italic> (Upper) or <italic>Hrd1</italic> (lower) promoter from genomic sequence from human, mouse, and rat. The numbering corresponds to the mouse sequence and is relative to the transcription start site (TSS). Mutations of the RBP-J-binding motifs within <italic>Sel1l</italic> or <italic>Hrd1</italic> promoter luciferase reporters (as in <bold>L</bold>, <bold>M</bold>) are shown. (<bold>F–I</bold>). Upper: Schematic diagram of the ChIP primer (P1–P3) locations across the <italic>Sel1l</italic> (<bold>F</bold>) <italic>Hrd1,</italic> (<bold>G</bold>) <italic>Edem1,</italic> (<bold>H</bold>) or <italic>Os9</italic> (<bold>I</bold>) promoter regions. TSS: transcription start site. Lower: Chromatin extracts from EL4 cells treated with PBS or 5 μg/ml DLL4 for 24 hr were subjected to ChIP using anti-RBP-J antibody, anti-NICD antibody, or normal IgG. Genomic regions of <italic>Sel1l</italic> (<bold>F</bold>), <italic>Hrd1</italic> (<bold>G</bold>), <italic>Edem1</italic> (<bold>H</bold>), or <italic>Os9</italic> (<bold>I</bold>) promoter (as in left panel) were tested for enrichment of RBP-J, NICD or IgG. Data are shown as percentage of input. (<bold>J</bold>) <italic>Sel1l</italic> or <italic>Hrd1</italic> promoter luciferase reporter was co-transfected with empty vector or different doses of NICD into HEK293T cells, and luciferase activity was measured 36 hr after transfection. pGL3 basic was used as control. (<bold>K and L</bold>) Wild-type or mutant (RBP-J motif mutations, as shown in <bold>E</bold>) <italic>Sel1l</italic> (<bold>K</bold>) or <italic>Hrd1</italic> (<bold>L</bold>) promoter luciferase reporter was transfected into EL4 cells which were treated with PBS or 5 μg/ml DLL4 for 24 hr before harvest. Luciferase activity was measured 36 hr after transfection. All luciferase data are presented relative to <italic>Renilla</italic> readings. Data are shown as mean ± s.d. Two-tailed Student’s t-tests (<bold>A, B, D, F-I, K, L</bold>) or one-way ANOVA with Bonferroni test (<bold>J</bold>) were used to calculate p values. n.s., not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Original western blot images shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig4-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig4-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Notch signal regulates ERAD genes expression.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of Notch target genes expression in EL4 cells after stimulation with 5 μg/ml Delta ligand 4 (DLL4) for 24 hr. Data are presented relative to <italic>Actb. n =</italic> 3. (<bold>B</bold>) Quantitative RT-PCR analysis of Notch target genes expression in primary DN3 thymocytes treated with 2 μM γ-secretase inhibitor DAPT for 5 hr. Data are presented relative to <italic>Actb. n =</italic> 3. (<bold>C</bold>) Expression of Notch1 on cell surface of different thymocyte subsets from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. Ctrl: <italic>n</italic> = 2. <italic>Sel1l</italic> CKO: <italic>n =</italic> 4. (<bold>D</bold>) Quantitative RT-PCR analysis of Notch target genes expression in primary DN3 thymocytes from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 4. Data are shown as mean ± s.d. Two-tailed Student’s t-tests (<bold>A–C</bold>) was used to calculate p values. n.s., not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig4-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig4-figsupp1-v3.tif"/></fig></fig-group><p>To further determine whether Notch regulates expression of ERAD component genes, we treated freshly isolated primary DN3 thymocytes with the highly specific γ-secretase inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester) that blocks ligand-induced cleavage of the Notch intracellular domain (NICD), preventing its nuclear translocation and subsequent transactivation of the RBP-J transcription factor at target genes (<xref ref-type="bibr" rid="bib13">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">De Obaldia et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Schmitt et al., 2004</xref>; <xref ref-type="bibr" rid="bib6">Bray, 2016</xref>). Indeed, treatment with DAPT significantly reduced expression of Notch target genes <italic>Hes1</italic>, <italic>Deltex1,</italic> and <italic>Ptcra</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>) and also reduced <italic>Sel1l, Hrd1</italic>, <italic>Os9,</italic> and <italic>Edem1</italic> expression in DN3 thymocytes (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These data demonstrate that Notch signals regulate expression of genes constituting the ERAD machinery.</p><p>Analysis of the promoters of the core ERAD genes, <italic>Sel1l</italic> and <italic>Hrd1</italic>, revealed conserved binding sites for RBP-J (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), the DNA binding partner and master transcription factor of the NICD transactivation complex (<xref ref-type="bibr" rid="bib11">Castel et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Tanigaki and Honjo, 2007</xref>). To interrogate how Notch regulates the ERAD gene components, we performed chromatin immunoprecipitation and qPCR of target DNA (ChIP-qPCR) experiments in EL4 cells. DLL4 stimulation of Notch signaling significantly induced NICD and RBP-J bindings at the promoters of <italic>Sel1l</italic>, <italic>Hrd1</italic>, <italic>Os9,</italic> and <italic>Edem</italic> (<xref ref-type="fig" rid="fig4">Figure 4F–I</xref>).</p><p>We cloned the <italic>Sel1l</italic> and <italic>Hrd1</italic> promoters containing the RBP-J-binding sites into the pGL3 firefly luciferase reporter and tested the regulation of these promoters by Notch. When co-transfected with promoter luciferase reporters into HEK293T cells, NICD potently induced both <italic>Sel1l</italic> and <italic>Hrd1</italic> promoter activity in a dose-dependent manner (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). In agreement, DLL4 stimulation of Notch signaling in EL4 cells also substantially activated <italic>Sel1l</italic> and <italic>Hrd1</italic> promoter activity (<xref ref-type="fig" rid="fig4">Figure 4K,L</xref>). Importantly, mutation of the RBP-J-binding sites abolished DLL4-driven induction of <italic>Sel1l</italic> or <italic>Hrd1</italic> luciferase reporter activity (<xref ref-type="fig" rid="fig4">Figure 4K,L</xref>). These data indicate that Notch signaling directly regulates expression of SEL1L ERAD machinery. Interestingly, although ERAD is known to regulate surface receptor expression in a substrate-specific manner (<xref ref-type="bibr" rid="bib57">van den Boomen and Lehner, 2015</xref>; <xref ref-type="bibr" rid="bib63">Xu et al., 2020</xref>), <italic>Sel1l</italic> deletion did not affect surface Notch1 protein levels in DN thymocyte populations (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Similarly, SEL1L had little impact on the expression of Notch target genes <italic>Hes1</italic> and <italic>Ptcra</italic> in DN3 thymocytes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). These results not only suggest that ERAD does not regulate Notch signaling per se but also imply that thymocyte β-selection defects in <italic>Sel1l CKO</italic> mice were not due to failure in Notch signal transduction.</p></sec><sec id="s2-6"><title>SEL1L is not required for pre-TCR signaling</title><p>The <italic>Tcrb</italic> allele is rearranged in DN2/DN3 thymocytes and the resulting TCRβ protein pairs with pre-Tα and CD3 complex proteins to form the pre-TCR which, together with Notch, transduces β-selection signals and promotes survival, proliferation and further differentiation of DN3 thymocytes (<xref ref-type="bibr" rid="bib14">Ciofani et al., 2004</xref>; <xref ref-type="bibr" rid="bib39">Michie and Zúñiga-Pflücker, 2002</xref>; <xref ref-type="bibr" rid="bib46">Sambandam et al., 2005</xref>). DN3 thymocytes that fail to undergo productive recombination of the <italic>Tcrb</italic> locus fail β-selection, do not complete the DN4-DP transition and are eliminated by apoptosis (<xref ref-type="bibr" rid="bib14">Ciofani et al., 2004</xref>). Therefore, to understand how SEL1L regulates β-selection thymocyte survival and the resulting DN-to-DP transition, we first asked whether <italic>Sel1l</italic>-deficiency caused defective V(D)J recombination. Genomic DNA analysis of <italic>Sel1l</italic>-deficient DN3 and DN4 thymocytes showed that recombination of <italic>Vb5-Jb2</italic>, <italic>Vb8-Jb2</italic>, and <italic>Vb11-Jb2</italic> gene segments were not altered (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), indicating that <italic>Sel1l</italic> deficiency does not affect <italic>Tcrb</italic> gene rearrangement.</p><p>Next, we asked whether SEL1L regulates the expression and signaling of the pre-TCR complex. Expression of intracellular TCRβ in pre-selected DN3a, post-selected DN3b and DN4 cells was comparable between control and <italic>Sel1l</italic> CKO mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,C</xref>). <italic>Sel1l</italic> deletion also had no impact on the expression of pre-TCR signaling intermediates including LCK and ZAP-70 in DN3 and DN4 thymocytes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>).</p><p>To further evaluate whether the <italic>Sel1l</italic> CKO mice phenotype was due to defective pre-TCR signaling, we introduced the MHCII-restricted TCR-β transgene OT-II into <italic>Sel1l</italic> CKO mice. As previously reported (<xref ref-type="bibr" rid="bib34">Kim et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">Marquis et al., 2014</xref>), expression of TCR transgenes like OT-II in early DN thymocytes can rescue β-selection defects caused by defective pre-TCR expression or signaling. However, the OT-II TCR transgene did not rescue T cell development in OT-II. <italic>Sel1l</italic> CKO mice which showed a &gt;80% decrease in thymic cellularity, DP and SP thymocytes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E–G</xref>). In addition, OT-II TCR failed to rescue impaired DN3 to DN4 thymocyte transition resulting from <italic>Sel1l</italic> deficiency as DN4 thymocytes were decreased ~60% in OT-II. <italic>Sel1l</italic> CKO mice compared to littermate controls (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1H</xref>). Taken together, these data implied that β-selection defects in <italic>Sel1l</italic> CKO mice were not due to defects in pre-TCR expression or signaling.</p></sec><sec id="s2-7"><title><italic>Sel1l</italic>-deficiency triggers unresolved ER stress during β-selection</title><p>To understand the molecular mechanism by which SEL1L ERAD regulates thymocyte survival and differentiation at β-selection, we performed RNA-seq on control and <italic>Sel1l</italic> CKO DN3 thymocytes. The most upregulated pathways in <italic>Sel1l</italic> CKO DN3 thymocytes were ER stress response and the UPR, including both IRE1α and PERK pathways (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref>). Gene set enrichment analysis (GSEA) also revealed enriched ER stress response in <italic>Sel1l</italic> CKO thymocytes (<xref ref-type="fig" rid="fig5">Figure 5C–E</xref>). These signatures hinted at elevated ER stress in <italic>Sel1l</italic> CKO DN3 thymocytes. Consistent with elevated ER stress, flow cytometry quantification of ER tracker dye staining indicated significant ER expansion in <italic>Sel1l</italic> CKO DN3 cells compared to control thymocytes (<xref ref-type="fig" rid="fig5">Figure 5F,G</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Sel1l</italic>-deficiency triggers unresolved ER stress during β-selection.</title><p>(<bold>A</bold>) Heatmap showing differentially expressed genes from the RNA-seq analysis of DN3 thymocytes sorted from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n =</italic> 4. (<bold>B</bold>) Gene Ontology (GO) analysis of the most significantly upregulated pathways in <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) DN3 thymocytes compared with control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) DN3 thymocytes. (<bold>C–E</bold>) Plots from GSEA analysis showing enrichment of Unfolded Protein Response (<bold>C</bold>), IRE1α (<bold>D</bold>), and PERK (<bold>E</bold>) pathways in <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) DN3 thymocytes compared to control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) DN3 thymocytes. (<bold>F and G</bold>) Representative histogram (<bold>F</bold>) and quantification(<bold>G</bold>) of ER-tracker staining in DN3 thymocytes sorted from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) and <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. Ctrl: <italic>n</italic> = 4; <italic>Sel1l</italic> CKO: <italic>n =</italic> 3. MFI, mean fluorescence intensity. (<bold>H</bold>) Western blot analysis of UPR pathway markers in primary DN3 thymocytes sorted from 6-week-old Ctrl or <italic>Sel1l</italic> CKO mice. β-ACTIN was used as loading control. The original western blot images are provided in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>. (<bold>I</bold>) PCR analysis of XBP1-splicing in DN3 thymocytes sorted from Ctrl or <italic>Sel1l</italic> CKO mice. Xbp1u: Unspliced Xbp1; Xbp1s: Spliced Xbp1. ACTIN was used as loading control. The original gel images are provided in <xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5—source data 2</xref>. (<bold>J and K</bold>) Representative histogram (<bold>J</bold>) and quantification (<bold>K</bold>) of unfolded/misfolded protein level measured by TMI in DN3 thymocytes sorted from Ctrl or <italic>Sel1l</italic> CKO mice. <italic>n</italic> = 3. (<bold>L</bold>) Schematic illustration of labeling and detection of misfolded and aggregated proteins with ProteoStat dye. (<bold>M and N</bold>) Representative images (<bold>M</bold>) and quantification (<bold>N</bold>) of protein aggregation measured by ProteoStat Protein Aggregation Detection Kit in primary DN3 thymocytes sorted from three pooled Ctrl or <italic>Sel1l</italic> CKO mice. Results are shown as mean ± s.d. Two-tailed Student’s t-tests (<bold>G, K, N</bold>) was used to calculate p values. **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Original western blot images shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig5-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Original gels images shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig5-data2-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig5-data3-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>SEL1L is not required for TCRβ gene rearrangement and pre-TCR signaling.</title><p>(<bold>A</bold>) PCR analysis of <italic>Vβ5-Jβ2</italic>, <italic>Vβ8-Jβ2</italic>, and <italic>Vβ11-Jβ2</italic> gene rearrangements using genomic DNA of DN3 and DN4 thymocytes sorted from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. The original gel images are provided in <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>. (<bold>B and C</bold>) Representative flow cytometry plots (<bold>B</bold>) and quantification (<bold>C</bold>) of intracellular TCRβ positive cells in DN3a, DN3b and DN4 thymocytes from Ctrl or <italic>Sel1l</italic> CKO mice. <italic>n</italic> = 5. (<bold>D</bold>) Western blot analysis of the expression of proteins involved in pre-TCR signaling in primary DN3 and DN4 thymocytes sorted from Ctrl or <italic>Sel1l</italic> CKO mice. β-ACTIN was used as loading control. The original western blot images are provided in <xref ref-type="supplementary-material" rid="fig5s1sdata2">Figure 5—figure supplement 1—source data 2</xref>. (<bold>E–H</bold>) Representative pseudocolor plots (<bold>E</bold>) quantification of total thymocytes (<bold>F</bold>) and cell numbers of indicated populations (<bold>G and H</bold>) from OT-II.Ctrl (<italic>OT-II; Sel1l<sup>flox/flox</sup></italic>) or OT-II. <italic>Sel1l</italic> CKO (<italic>OT-II; Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) mice. OT-II.Ctrl: <italic>n</italic> = 7. OT-II. <italic>Sel1l</italic> CKO: <italic>n</italic> = 6. Data are shown as mean ± s.d. Two-tailed Student’s t-tests (<bold>C, F–H</bold>) was used to calculate p values. n.s., not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Original gels images shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig5-figsupp1-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Original western blot images shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig5-figsupp1-data2-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata3"><label>Figure 5—figure supplement 1—source data 3.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig5-figsupp1-data3-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig5-figsupp1-v3.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title><italic>Sel1l</italic> knockout induces ER stress.</title><p>(<bold>A</bold>) Western blot analysis of UPR pathway markers in primary DN4 thymocytes sorted from 6-week-old Ctrl or <italic>Sel1l</italic> CKO mice. β-ACTIN was used as loading control. The original western blot images are provided in <xref ref-type="supplementary-material" rid="fig5s2sdata1">Figure 5—figure supplement 2—source data 1</xref>. (<bold>B</bold>) PCR analysis of XBP1-splicing in DN4 thymocytes sorted from Ctrl or <italic>Sel1l</italic> CKO mice. Xbp1u: Unspliced Xbp1; Xbp1s: Spliced Xbp1. ACTIN was used as loading control. The original gel images are provided in <xref ref-type="supplementary-material" rid="fig5s2sdata2">Figure 5—figure supplement 2—source data 2</xref>. (<bold>C and D</bold>) Quantitative RT-PCR analysis of ER chaperone genes expression in DN3 (<bold>C</bold>) and DN4 (<bold>D</bold>) thymocytes sorted from 6-week-old Ctrl or <italic>Sel1l</italic> CKO mice. Data are presented relative to <italic>Actb. n</italic> = 3. Data are shown as mean ± s.d. Two-tailed Student’s t-tests was used to calculate p values. n.s., not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Original western blot images shown in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig5-figsupp2-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s2sdata2"><label>Figure 5—figure supplement 2—source data 2.</label><caption><title>Original gels images shown in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-fig5-figsupp2-data2-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s2sdata3"><label>Figure 5—figure supplement 2—source data 3.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig5-figsupp2-data3-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig5-figsupp2-v3.tif"/></fig></fig-group><p>To further ascertain the induction of ER stress following <italic>Sel1l</italic> deletion, we sorted DN3 and DN4 thymocytes from control or <italic>Sel1l</italic> CKO mice and examined the activation of all three UPR branches. We found a significant increase in IRE1α proteins and in the splicing of its substrate <italic>Xbp1</italic> in <italic>Sel1l</italic> CKO thymocytes (<xref ref-type="fig" rid="fig5">Figure 5H,I</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A,B</xref>). We also observed increased PERK and eIF2α phosphorylation as well as increased ATF4 and BIP proteins in <italic>Sel1l</italic> CKO DN3 thymocytes (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Various ER chaperones, including <italic>Calreticulin</italic>, <italic>Grp94 (Hsp90b1)</italic>, <italic>Hspa5(Bip), Hyou1</italic>, and <italic>Canx</italic>, and other members of ERAD pathway were markedly upregulated in <italic>Sel1l</italic> CKO DN3 and DN4 thymocytes (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C,D</xref>). These data indicate that <italic>Sel1l</italic> deletion triggers ER stress leading to activation of all three UPR branches in DN thymocytes.</p><p>As ERAD alleviates proteotoxic stress by promoting the degradation of misfolded or unfolded proteins, we hypothesized that loss of SEL1L increased proteotoxic stress during β-selection. Indeed, we found that <italic>Sel1l</italic> CKO DN3 thymocytes exhibited significantly higher staining for misfolded/unfolded proteins with TMI (<xref ref-type="fig" rid="fig5">Figure 5J,K</xref>). We also employed proteostat, a molecular rotor dye, to examine protein aggregation in DN3 thymocytes. The proteostat dye specifically intercalates into the cross-beta spine of quaternary protein structures typically found in misfolded and aggregated proteins, which inhibits the dye’s rotation and leads to a strong fluorescence (<xref ref-type="fig" rid="fig5">Figure 5L</xref>). <italic>Sel1l</italic> CKO DN3 thymocytes displayed more protein aggregates compared with control thymocytes (<xref ref-type="fig" rid="fig5">Figure 5M,N</xref>). Collectively, these results corroborate that DN thymocytes lacking SEL1L accumulate misfolded/unfolded proteins leading to proteotoxic stress that then trigged the UPR and eventually apoptosis.</p></sec><sec id="s2-8"><title>PERK signaling drives β-selected thymocyte apoptosis in <italic>Sel1l</italic> CKO mouse</title><p>To determine whether upregulation of the UPR contributed to post-β-selected thymocyte apoptosis and the <italic>Sel1l</italic> CKO mouse phenotype, we generated <italic>Sel1l/Xbp1</italic> double-knockout (<italic>Sel1<sup>flox/flox</sup>.Xbp1<sup>flox/flox</sup>.CD2</italic>-iCre), and <italic>Sel1l/Perk</italic> double-knockout (<italic>Sel1<sup>flox/flox</sup>.Perk<sup>flox/flox</sup>.CD2</italic>-iCre) mice. Deletion of <italic>Xbp1</italic> in <italic>Sel1l</italic> CKO mice did not rescue thymocyte development (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). In fact, <italic>Sel1l/Xbp1</italic> double-knockout (DKO) mice showed more severe thymocytes development defects including a more than 95% loss in thymus cellularity and DP thymocyte numbers (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). The DN3 and DN4 thymocytes from <italic>Sel1l/Xbp1</italic> DKO exhibited much more <italic>Chop</italic> expression (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). These data suggest that induction of the IRE1α/XBP1 pathway functions as a compensatory adaptative pathway to restrain <italic>Sel1l</italic>-deficiency induced ER stress.</p><p>In contrast to deletion of <italic>Xbp1</italic>, we found that deletion of <italic>Perk</italic> significantly rescued the <italic>Sel1l</italic> CKO mouse phenotype evident in the near complete restoration of thymus cellularity, DP and SP thymocyte cell numbers (<xref ref-type="fig" rid="fig6">Figure 6A,B</xref>). <italic>Perk</italic> deletion also restored peripheral T cells in spleen and lymph nodes compared to <italic>Sel1l</italic> CKO mice (<xref ref-type="fig" rid="fig6">Figure 6C–F</xref>). Consistent with the rescue, <italic>Perk</italic> deletion significantly reduced <italic>Sel1l</italic>-deficiency induced <italic>Chop</italic> induction (<xref ref-type="fig" rid="fig6">Figure 6G</xref>) and thymocyte apoptosis (<xref ref-type="fig" rid="fig6">Figure 6H,I</xref>) and restored normal cell cycle kinetics to <italic>Sel1l</italic> CKO DN4 thymocytes (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). As <italic>Perk</italic> deficiency alone had no effect on T cell development (<xref ref-type="fig" rid="fig6">Figure 6A–I</xref>), these results indicate that activated PERK signaling contributed to the apoptosis of DN3/DN4 thymocytes that impaired β-selection in <italic>Sel1l</italic> CKO mice. Collectively, we conclude that SEL1L-ERAD promotes β-selected DN thymocyte differentiation by maintaining ER proteostasis and suppressing ER stress-induced cell death through the PERK pathway.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>PERK signaling drives β-selected thymocyte apoptosis in <italic>Sel1l</italic> CKO mouse.</title><p>(<bold>A and B</bold>) Representative images of thymus (<bold>A</bold>) and quantification of total thymocytes, DP, SP4 and SP8 thymocytes (<bold>B</bold>) from age (6-week-old) and gender-matched control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>), <italic>Sel1l</italic> KO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre), <italic>Perk</italic> KO (<italic>Perk<sup>flox/flox</sup>; CD2</italic>-iCre)and <italic>Sel1l</italic>/<italic>Perk</italic> double knockout (DKO. <italic>Sel1l<sup>flox/flox</sup>, Perk<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 3–5 each group. (<bold>C and D</bold>) Representative images of spleen (<bold>C</bold>) and quantification of total splenocytes, total CD3<sup>+</sup> T cells, CD4<sup>+</sup> T cells, and CD8<sup>+</sup> T cells (<bold>D</bold>) from the same mice with indicated genotype as in <bold>A</bold> and <bold>B</bold>. <italic>n</italic> = 3–5 each group. (<bold>E and F</bold>) Representative images of the inguinal (left) lymph node (<bold>E</bold>) and quantification of total lymphocytes, total CD3<sup>+</sup> T cells, CD4<sup>+</sup> T cells, and CD8<sup>+</sup> T cells (<bold>F</bold>) from the same mice with indicated genotype as in <bold>A</bold> and <bold>B</bold>. <italic>n</italic> = 3–5 each group. (<bold>G</bold>) Quantitative RT–PCR analysis of <italic>Chop</italic> expression in DN3 thymocytes sorted from mice with indicated genotype. <italic>n</italic> = 3–5 each group. (<bold>H and I</bold>) Representative images (<bold>H</bold>) and quantification (<bold>I</bold>) of cleaved caspase-3 (CC3)-positive cells in the thymus of 6- to 8-week-old gender-matched mice with indicated genotype. Twelve fields were counted at ×20 magnification from four mice with indicated genotype. Scale bars are indicated. Data are representative of three independent experiments and are shown as mean ± s.d. The statistical signiﬁcance was calculated by two-tailed unpaired t-test (<bold>D, F</bold>) One-way ANOVA with turkey test (<bold>B, G</bold>) or one-way ANOVA with Bonferroni test (<bold>I</bold>). ns, not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig6-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>XBP1 functions as a compensatory adaptative mechanism in <italic>Sel1l</italic> CKO mouse.</title><p>(<bold>A</bold>) Quantification of total cellularity and DP cell numbers of 6–8 week-old gender-matched control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>), <italic>Sel1l</italic> KO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre), <italic>Xbp1</italic> KO (<italic>Xbp1 <sup>flox/flox</sup>; CD2</italic>-iCre), and <italic>Sel1l</italic>/<italic>Xbp1</italic> double knockout (DKO, <italic>Sel1l<sup>flox/flox</sup>; Xbp1<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 3–6/each group. (<bold>B</bold>) Quantitative RT-PCR analysis <italic>Chop</italic> expression in DN3 thymocytes sorted from mice with indicated genotype. Data are presented relative to <italic>Actb</italic>. (<bold>C</bold>) Cell cycle analysis of DN4 thymocytes from age (6-week-old) and gender-matched control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>), <italic>Sel1l</italic> KO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre), <italic>Perk</italic> KO (<italic>Perk<sup>flox/flox</sup>; CD2</italic>-iCre) and <italic>Sel1l</italic>/<italic>Perk</italic> double knockout (DKO. <italic>Sel1l<sup>flox/flox</sup>; Perk<sup>flox/flox</sup>; CD2</italic>-iCre) mice. <italic>n</italic> = 3–5 each group. Data are shown as mean ± s.d. The statistical signiﬁcance was calculated by two-tailed unpaired t-test (<bold>A, B</bold>) or One-way ANOVA with Turkey test (<bold>C</bold>). n.s., not significant, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Excel file containing numerical values shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69975-fig6-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69975-fig6-figsupp1-v3.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we have uncovered a novel 'Notch-ERAD' axis in thymocyte development. In the absence of the core ERAD protein SEL1L, thymocytes failed to survive β-selection and T cell development was severely impaired. Our results imply that the protein synthesis and folding demands during β-selection require a robust proteome quality control monitoring which is accomplished by the ERAD in thymocytes transitioning from the DN3 to DN4 stage. Thus, induction of the SEL1L axis of ERAD, which peaks at the DN3 stage, represents a previously undefined and critical ER proteostasis checkpoint during β-selection. It is notable that this ER proteostasis checkpoint is also regulated by the same Notch signals which, together with the pre-TCR, induce β-selection in DN3 thymocytes. We identified that Notch1 and RBP-J directly bind to most ERAD gene promoters and directly regulate their expression. In fact, we observed that Notch-signal induced SEL1L protein levels exceeded the change in <italic>Sel1l</italic> mRNA expression (<xref ref-type="fig" rid="fig4">Figure 4B,C</xref>), suggesting additional post-transcriptional regulation of ERAD by Notch that warrants further investigation.</p><p>ERAD and UPR are two key ER protein quality control machineries that are activated at different thresholds. ERAD is responsible for the clearance of misfolded proteins at steady-state and is constitutively activated regardless of ER stress. In contrast, the UPR is a stress response pathway that is triggered when the accumulation of misfolded and unfolded proteins exceed the ER folding capacity. Existing evidence suggest that UPR pathways like the IRE1α-XBP1 axis appear to selectively regulate hematopoietic cell differentiation programs but individual UPR enzymes influence early thymopoiesis remain to be fully characterized. For instance, the IRE1α-XBP1 is essential for eosinophil (<xref ref-type="bibr" rid="bib5">Bettigole et al., 2015</xref>), dendritic cell (<xref ref-type="bibr" rid="bib17">Cubillos-Ruiz et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Iwakoshi et al., 2007</xref>; <xref ref-type="bibr" rid="bib42">Osorio et al., 2014</xref>), NK (<xref ref-type="bibr" rid="bib19">Dong et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Wang et al., 2019</xref>), and plasma cell (<xref ref-type="bibr" rid="bib44">Reimold et al., 2001</xref>; <xref ref-type="bibr" rid="bib49">Shapiro-Shelef and Calame, 2005</xref>) differentiation. Unlike the marked defect in thymocyte development in the absence of SEL1L-ERAD, our current study now clearly demonstrates that individual UPR regulators are dispensable for β-selection and subsequent stages of thymocyte maturation. We specifically found that deletion of the individual UPR master regulators XBP1, ATF6, or PERK had no overt impact on αβ T cell development in the thymus and peripheral tissues. Nevertheless, our results don’t exclude the possibility that redundancy might exist among the UPR pathways during thymocyte development.</p><p><italic>Sel1l-</italic>deficiency impaired the survival of DN thymocytes following β selection and resulted in the inability of DN3 thymocytes to expand and progress to DP thymocytes. Interestingly, this phenotype was not due to defective rearrangement of TCRβ nor defective Notch or pre-TCR signaling which both activate pro-survival genes in β-selected thymocytes (<xref ref-type="bibr" rid="bib15">Ciofani and Zúñiga-Pflücker, 2005</xref>; <xref ref-type="bibr" rid="bib35">Kreslavsky et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Zhao et al., 2019</xref>). Instead, our genetic inactivation delineate a pro-apoptotic pathway driven by the PERK axis. While all three UPR pathways can promote apoptosis and appear to be upregulated in <italic>Sel1l</italic> CKO thymocytes, it is notable that only PERK axis induces apoptosis in <italic>Sel1l</italic> CKO thymocytes. On the contrary, induction of the IRE1α-XBP1 axis of the UPR can help cells adapt to stress. Consistent with this view, deletion of <italic>Xbp1</italic> in <italic>Sel1l</italic> CKO thymocytes exacerbated defects in thymocyte development unlike PERK inactivation which restored T cell development from <italic>Sel1l</italic> CKO thymocytes.</p><p>Although αβ T and γδ T cells develop in the thymus from the same thymic seeding progenitors, the function of ERAD appears to be restricted to αβ T cells. While future studies are needed to determine the alternative protein quality control mechanism regulating γδ T cell development, our findings are consistent with the selective requirement for Notch in driving β-selection (<xref ref-type="bibr" rid="bib36">Maillard et al., 2006</xref>), a key developmental checkpoint unique to the αβ T cell differentiation program. In addition, DN thymocytes undergoing β selection expand more than 100-fold, a situation that likely explains their increased translational activity. That post-β-selected DN thymocytes displayed markedly low levels of misfolded/unfolded proteins support the view that upregulation of the SEL1L-ERAD axis in DN3 thymocytes provides a mechanism to alleviate deleterious proteotoxic stress that compromise the fitness of DN4 thymocytes. In this way, SEL1L-ERAD safeguards to DN3/DN4 thymocyte pool to ensure that the maximum number of DN thymocytes expressing a functional TCRβ protein progress to the DP stage to audition for positive selection.</p><p>Activating <italic>NOTCH1</italic> mutations are found in more than 50% of human T cell acute lymphoblastic leukemia (T-ALL) patients (<xref ref-type="bibr" rid="bib61">Weng et al., 2004</xref>) wherein Notch plays pivotal roles in regulating the survival and metabolism of T-ALL cells (<xref ref-type="bibr" rid="bib1">Aster et al., 2011</xref>; <xref ref-type="bibr" rid="bib23">García-Peydró et al., 2018</xref>). It will be of interest in future studies to investigate whether Notch-regulated ERAD also promotes ER proteostasis and sustains T-ALL survival by clearing misfolded proteins and restricting ER stress-induced cell death.</p><p>In summary, our study reports a previously unknown function of Notch in maintaining proteostasis and protecting post-β-selection thymocytes from ER stress by upregulating ERAD. We propose that in addition to driving energy metabolism and survival programs demanded by proliferating thymocytes following β-selection, Notch signals in parallel activate the ERAD machinery in DN3 thymocytes to clear misfolded proteins. Thus, stringent protein quality control through the SEL1L-ERAD pathway is required for successful β-selection and the development of the αβ T cells that mediate adaptive immunity.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>Key resources table is in Appendix 1.</p><sec id="s4-1"><title>Mice</title><p>The mice were maintained in a pure C57BL/6 background and kept under specific-pathogen-free conditions in the transgenic mouse facility of the Baylor College of Medicine (22–24°C, 30–70% humidity with a 12 hr dark and 12 hr light cycle). <italic>Sel1l</italic><sup>flox/flox</sup> and <italic>Xbp1<sup>flox/flox</sup></italic> were described previously (<xref ref-type="bibr" rid="bib63">Xu et al., 2020</xref>)<italic>, Perk<sup>flox/flox</sup></italic> mice were purchased from Jackson Laboratory (Stock No. 023066). The floxed mice were crossed with either h<italic>CD2</italic>-iCre (The Jackson Laboratory, 008520) or <italic>Cd4-Cre</italic> (The Jackson Laboratory, 022071) mice to generate <italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre<italic>, Sel1l<sup>flox/flox</sup>; Cd4-Cre, Xbp1</italic><sup>flox/flox</sup><italic>; CD2</italic>-iCre, or <italic>Perk</italic><sup>flox/flox</sup><italic>; CD2</italic>-iCre mice. The <italic>Sel1l<sup>flox/flox</sup>; Xbp1<sup>flox/flox</sup>; CD2</italic>-iCre mice and <italic>Sel1l<sup>flox/flox</sup>; Perk<sup>flox/flox</sup>; CD2</italic>-iCre mice were generated by crossing <italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre mice with <italic>Xbp1<sup>flox/flox</sup></italic> or <italic>Perk<sup>flox/flox</sup></italic> mice respectively. <italic>Atf6<sup>flox/flox</sup>; Vav1-</italic>iCre mice were generated by crossing <italic>Atf6l<sup>flox/flox</sup></italic> (The Jackson Laboratory, 028253) with <italic>Vav1-</italic>iCre mice (The Jackson Laboratory, 008610). <italic>Sel1l</italic> CKO; OTII transgenic mice were generated by crossing <italic>Sel1l</italic> CKO mice with OTII transgenic mice (The Jackson Laboratory, 004194).</p><p>Six- to 8-week-old gender-matched mice were used for phenotype analysis and in vitro assay. For the bone marrow transplantation assays, female C57BL/6-Ly5.1 (CD45.1<sup>+</sup>) mice (Charles River, 564) were used at 8–12 weeks of age. All procedures were approved by the Baylor College of Medicine Institutional Animal Care and Use Committee or Case Western Reserve University Institutional Animal Care and Use Committee. The study is compliant with all of the relevant ethical regulations regarding animal research.</p></sec><sec id="s4-2"><title>In vivo assays</title><p>For the competitive bone marrow transplantation experiments, CD45.1<sup>+</sup>-recipient mice were lethally irradiated (10 Gy, delivered with two equal doses 4 hr apart) and injected retro-orbitally with 1x10<sup>6</sup> whole bone marrow cells from <italic>Sel1l<sup>flox/flox</sup></italic> or <italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre mice with an equal number of CD45.1<sup>+</sup> competitor BM cells. For the BrdU incorporation assay, the mice were injected intraperitoneally with single dose of BrdU (BD, 559619; 50 mg/kg body weight) 2 hr before euthanization.</p></sec><sec id="s4-3"><title>Flow cytometry and cell sorting</title><p>Single-cell suspensions from thymus, spleen and lymph nodes were obtained by passing the tissues through a 70 μm strainer. Bone marrow was removed from femurs and tibiae by flushing with PBS, 2% FBS. For bone marrow and spleen cell suspensions, red blood cells were removed by incubating with RBC Lysis Buffer (Biolegend, 420301). 1 × 10<sup>6</sup> to 2 × 10<sup>6</sup> cells were stained with antibodies at 4°C for 30 min in phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA), followed by washing to remove the unbound antibodies.</p><p>Antibodies used for flow cytometry: The biotin-conjugated lineage markers for excluding non-DN cells are purchased from BioLegend: CD11b (M1/70, 101204), CD11c (N418, 117303), Ter119 (Ter119, 116204), Gr-1 (RB6-8C5, 108404), CD49b (DX5, 108904), and B220 (RA3-6B2, 103204). CD4 (BV650, RM4-5, 100546, BioLegend), CD8 (AF700, 53–6.7, 100730, BioLegend), CD25 (PE-Cy7, 3C7, 101915, BioLegend), CD44 (PE594, IM7, 103056, BioLegend), c-Kit (APC-Cy7, 2B8, 105838, Biolegend), γδTCR (PE, GL3, 118108, Biolegend), and CD27 (APC, LG.3A10, 124211, BioLegend) antibodies were used for analysis of ETP to SP cells in the thymus. CD4 (BV650, RM4-5, 100546, BioLegend), CD8 (AF700, 53–6.7, 100730, BioLegend), γδTCR (APC, GL3, 118115, BioLegend), B220 (PB, RA3-6B2, 103230, BioLegend), and NK1.1 (FITC, PK136, 108706, BioLegend) antibodies were used for the analysis of mature cells in the spleen and lymph nodes. Anti-CD45.1 (FITC, A20, 110706, BioLegend) and CD45.2 (APC, 104, 109814, BioLegend) antibodies were used for the analyses of donor chimerism in the bone marrow transplantation assay. All antibodies used in this study are listed in Appendix 1. Dead cells were excluded by 4,6-diamidino-2-phenylindole (DAPI) staining.</p><p>For cell sorting, DN thymocytes were purified by negative selection using a magnetic bead/column system (CD4 (L3T4) MicroBeads, 130-117-043; CD8a (Ly-2) MicroBeads, 130-117-044; LD Columns, 130-042-901; all purchased from Miltenyi Biotec) in accordance to the manufacturer’s instructions. The pre-enriched DN cells were further stained as described above to sort DN2, DN3, or DN4 cells. Dead cells were excluded by DAPI staining.</p><p>Flow cytometry data were collected using BD FACS Diva eight on a BD LSR II or BD Fortessa analyzer. The cell-sorting experiments were performed on a FACS Aria II cell sorter (BD). The acquired data were analyzed using the FlowJo 10 software.</p></sec><sec id="s4-4"><title>Apoptosis assay</title><p>For Annexin V staining, thymocytes were first stained with surface makers and then stained with Annexin V antibody for 30 min at room temperature in Annexin V binding buffer (TONBO, TNB-5000-L050). The cells were resuspended in Annexin V binding buffer with 1 μg/ml DAPI for analysis.</p></sec><sec id="s4-5"><title>Cell proliferation assay</title><p>For cell cycle analysis, thymocytes were stained with surface markers followed by fixation and permeabilization with eBioscience Transcription Factor Staining Buffer Set (Life Technologies, 00-5523-00). The cells were then stained with anti-Ki-67 (FITC, 16A8, 652409, Biolegend) and DAPI for cell cycle analysis. For BrdU staining, total thymocytes were stained with surface markers to define each subset, followed by intracellular staining using the BrdU staining kit according to the manufacturer’s instructions (BD Biosciences, 559619).</p></sec><sec id="s4-6"><title>Cell culture and cell lines</title><p>OP9 bone marrow stromal cells expressing the Notch ligand DL-1 (OP9-DL1) were kindly provided by Dr. Juan Carlos Zúñiga-Pflücker (University of Toronto). The OP9-DL1 cells were cultured and maintained in αMEM medium, supplemented with 10% FBS (Gibco), penicillin (100 μg/mL), and streptomycin (100 U/mL) (Invitrogen). For thymocytes co-cultures, the sorted DN2 or DN3 cells were plated onto conﬂuent OP9-DL1 monolayers (70–80% conﬂuent) with addition of 5 ng/ml recombinant murine interleukin-7 (PeproTech) and 5 ng/ml Flt3L (PeproTech). Cells were harvested at different time points, filtered through 40 μm cell strainer, and stained with antibodies including ani-CD45 V450 (Tonbo, 75–0451 U100), anti-CD4 BV650 (Biolegend, 100546), anti-CD8a AF700 (Biolegend, 100730), anti-CD44 FITC (Biolegend, 103006), or anti-CD25 APC (Biolegend, 101910), followed by staining with Annexin V PE (Biolegend, 640908) and DAPI (4,6-diamidino-2-phenylindole, Invitrogen, D1306). EL4 cells (ATCC-TIB39) and HEK293T cells (ATCC CRL-3216) were cultured in DMEM with 10% FBS (Gibco), penicillin (100 μg/mL) and streptomycin (100 U/mL) (Invitrogen). No cell lines were listed in the database of cross-contaminated or misidentified cell lines by International Cell Line Authentication Committee (ICLAC). Cell lines from ATCC were authenticated by the STR profiling method and tested as mycoplasma contamination free by ATCC.</p></sec><sec id="s4-7"><title>Immunohistochemical staining</title><p>Thymus was fixed in fresh 4% paraformaldehyde for 24 hr and stored in 70% ethanol until paraffin embedding. Hematoxylin and eosin staining were performed on 5 μm–thick paraffin sections. For cleaved caspase-3 IHC, the anti-cleaved caspase-3 antibody (1:50, Cell Signaling Technology #9661) was used. Slides were incubated with Envision Labeled Polymer-HRP Anti-Rabbit (Dako, K4002) for 30 min. Sections were developed with DAB+ solution (Dako, K3468) and counterstained with Harris Hematoxylin. Imaging analysis was performed with ImageJ (FIJI) to automatically count the labeled cells in each region, the data were shown as number of positive cells per region.</p></sec><sec id="s4-8"><title>RNA extraction and quantitative real-time PCR</title><p>Thymocytes were sorted directly into TRIzol LS reagent (Invitrogen, 10296010). Total RNA was extracted according to the manufacturer’s instructions. Total RNA was reverse-transcribed using High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, 4368813). Quantitative real-time PCR was performed using PowerUp SYBR Green Master Mix (Thermo Fisher Scientific, A25778) on QuantStudio six real-time PCR system (Applied Biosystems). The primer sequences are listed in Appendix 1.</p></sec><sec id="s4-9"><title>Western blot analysis</title><p>Western blot was performed as described previously (<xref ref-type="bibr" rid="bib63">Xu et al., 2020</xref>). Approximately 5 × 10<sup>5</sup> DN3 cells were sorted directly into 250 μl PBS containing 20% trichoracetic acid (TCA). The concentration of TCA was adjusted to 10% after sorting and cells were incubated on ice for 30 min before centrifugation at 13,000 rpm for 10 min at 4°C. Precipitates were washed twice with pure acetone (Fisher scientific, A18-4) and solubilized in 9 M urea, 2% Triton X-100, and 1% dithiothreitol (DTT) in 1 x LDS sample buffer (Invitorgen, NP0007). Samples were separated on NuPAGE 4–12% Bis-Tris protein gels (Invitrogen, NP0336BOX) and transferred to PVDF membrane (Millipore). The blots were incubated with primary antibodies overnight at 4°C and then with secondary antibodies. Blots were developed with the SuperSignal West Femto chemiluminescence kit (Thermo Scientific, 34096). Antibodies and reagents used are in Appendix 1. The original western blot images are in source data files.</p></sec><sec id="s4-10"><title>RNA-seq and analysis</title><p>DN3 thymocytes were directly sorted into TRIzol LS (ThermoFisher, cat. 10296028) and RNA was extracted following the standard protocol. The cDNA libraries were prepared using Truseq Stranded mRNA Kit (Illumina, California, USA # 20020594). Sequencing was performed on Illumina HiSeq 2000 (Illumina, California, USA), 150 bp paired end. Quality control was performed using FastQC. Raw reads were aligned to mouse genome GRC38 using STAR (2.5.2b) and counts for each protein-coding gene were obtained with HTSeq (2.7). DESeq2 package (1.26.0) in R (3.6.1) was used to perform analysis of differential gene expression. Upregulated genes (with adjusted p value &lt; 0.05, log2 fold change &gt; 0.59) were selected for Gene Ontology (GO) analysis using Enrichr (<ext-link ext-link-type="uri" xlink:href="https://maayanlab.cloud/Enrichr/">https://maayanlab.cloud/Enrichr/</ext-link>). We further performed Gene Set Enrichment Analysis (GSEA) using fgsea package (1.11.2) with padj-preranked gene lists and mouse gene set collection from Bader Lab. Heatmaps were generated with pheatmap (1.0.12).</p></sec><sec id="s4-11"><title>Chromatin immunoprecipitation (ChIP) assay</title><p>For <xref ref-type="fig" rid="fig4">Figure 4C</xref>, cell culture plates were pre-coated with PBS or 5 μg/ml recombinant mouse DLL4 (BioLegend, #776706) overnight at 4°C before seeding EL4 cells. For <xref ref-type="fig" rid="fig4">Figure 4B,F–I,K and L</xref>, soluble DLL4 (5 μg/ml) was used. EL4 cells were incubated with soluble DLL4 for 24 hr before crosslinked with 1% formaldehyde for 10 min at room temperature. Reaction was quenched with 125 mM glycine. ChIP was performed as previously described (<xref ref-type="bibr" rid="bib66">Zhao et al., 2018</xref>) with NOTCH1 NICD antibody (Abcam, ab27526), RBPJ antibody (Cell Signaling Technology, #5313), or normal rabbit IgG (Cell Signaling Technology, #2729). The sequences of all ChIP primers are listed in Appendix 1.</p></sec><sec id="s4-12"><title>Luciferase assay</title><p>The firefly luciferase reporter for <italic>Sel1l</italic> or <italic>Hrd1</italic> (<italic>Syvn1</italic>) promoter was constructed by cloning the genomic region into the <italic>Mlu</italic>I and <italic>Xho</italic>I sites or the <italic>Mlu</italic>I and <italic>Hind</italic>III sites in the pGL-3 basic vector (Promega), respectively. Mutations were made by overlap extension polymerase chain reaction as previously described (<xref ref-type="bibr" rid="bib8">Bryksin and Matsumura, 2010</xref>). All constructs were verified by DNA sequencing. The sequences of all primers are listed in Appendix 1. HEK293T cells were transfected with <italic>Sel1l</italic> or <italic>Hrd1</italic> promoter constructs, pRL-PGK (Promega) and 3xFlag-NICD1 (Addgene, #20183) or empty using Lipofectamine 3000 (Invitrogen, L3000015). Cell lysates were collected 48 hr after transfection, and luciferase activities were analyzed using the dual-luciferase reporter assay system (E1910, Promega). pRL-PGK, which expresses Renilla luciferase, was used as the internal control for adjustment of discrepancies in transfection and harvest efficiencies. EL4 cells were transfected with <italic>Sel1l</italic> or <italic>Hrd1</italic> promoter constructs and pRL-PGK (Promega) using Lipofectamine 3000 (Invitrogen, L3000015). Cells were incubated with PBS or 5 μg/ml recombinant mouse DLL4 (BioLegend, #776706) for 24 hr before analysis.</p></sec><sec id="s4-13"><title>V(D)J recombination assay</title><p>A total of 5 × 10<sup>5</sup> DN3 thymocytes were sorted from control (Ctrl, <italic>Sel1l<sup>flox/flox</sup></italic>) or <italic>Sel1l</italic> CKO (<italic>Sel1l<sup>flox/flox</sup>; CD2</italic>-iCre) thymus and subjected to genomic DNA isolation using PureLink Genomic DNA Mini Kit (K1820-02) according to the manufacturer’s instructions. The amplification of eF-1 fragment was used as input control. The primers used for Vβ5-Jβ2, Vβ8- Jβ2, Vβ11-Jβ2, and eF1 are listed inAppendix 1. PCR products were resolved by 2% agarose gel electrophoresis.</p></sec><sec id="s4-14"><title>ER tracker staining</title><p>Sorted DN3 thymocytes were washed with PBS, incubated with 1 μM ER-Tracker Green (Thermo Fisher, E34251) in PBS for 15 min at 37°C. The cells were then washed and resuspended in PBS, and analyzed by flow cytometry.</p></sec><sec id="s4-15"><title>Tetraphenylethene maleimide (TMI) staining</title><p>5x10<sup>6</sup> thymocytes were stained for cell surface markers as described above. After surface markers staining, cells were washed twice with PBS. Tetraphenylethene maleimide (TMI; 2 mM in DMSO) was diluted in PBS to reach 50 μM final concentration and stained samples for 30 min at 37°C. Samples were washed once with PBS and analyzed by flow cytometry.</p></sec><sec id="s4-16"><title>In vivo measurement of protein synthesis</title><p>O-propargyl-puromycin (OPP; MedChem Source LLP) stock dissolved in 10% DMSO/PBS was diluted in PBS for intraperitoneal injection at 50 mg/kg. Mice were weighed, individually injected with OPP or vehicle, and euthanized 1 hr after injection. Thymuses were immediately harvested. Thymocytes were isolated and stained for surface antigens and viability dyes, which was followed by fixation and permeabilization according to the Click-iT Plus OPP Alexa Fluor 647 Protein Synthesis Assay Kit (ThermoFisher Scientific). Briefly, after incubation cells were subsequently fixed in 4% paraformaldehyde, permeabilized with 0.5% Triton-X100, then incubated with the AF647 reaction cocktail. Samples were acquired using a BD LSRFortessa and analyzed using FlowJo (Becton Dickinson) as per flow cytometry methods.</p></sec><sec id="s4-17"><title>Protein aggregation detection assay</title><p>The PROTEOSTAT Aggresome Detection kit (Enzo Life Sciences, ENZ-51035–0025) was used to detect protein aggregates in freshly sorted DN3 thymocytes according to the manufacturer’s instructions. DN3 thymocytes were fixed, permeabilized and incubated with PROTEOSTAT dye (1:10,000 dilution) for 30 min at room temperature. Nuclei were counterstained with DAPI. Samples stained with DAPI only were used as negative controls. Images (16-bit greyscale TIFFs) were analyzed using CellProfiler v2.2. In brief, the DAPI channel images were first smoother with a median filter and nuclei identified with automatic thresholding and a fixed diameter. Nuclei touching the border of the image are eliminated. Touching nuclei are separated with a watershed algorithm. Then, cell boundaries were identified by watershed gradient based on the dye signal, using nuclei as a seed. Metrics were extracted from the cell, cytoplasm, and nuclear compartments.</p></sec><sec id="s4-18"><title>TUNEL staining</title><p>TUNEL staining was performed on paraffin-embedded tissue sections using the In Situ Cell Death Detection Kit (catalog 11684795910, Roche) following the manufacturer’s instructions. Sections were counterstained with DAPI, and images were captured under fluorescence microscope. Tissue sections incubated with TUNEL reaction buffer without dTd enzyme served as negative controls. Tissue sections treated with DNase I served as positive controls. The quantification of TUNEL<sup>+</sup> cells was performed with ImageJ (FIJI) to automatically count the labeled cells in each region. The data were presented as number of positive cells per region.</p></sec><sec id="s4-19"><title>Statistics and reproducibility</title><p>Data are expressed as the mean ± s.d. or mean ± s.e.m. as indicated in the figure legends; <italic>n</italic> is the number of independent biological replicates, unless specifically indicated otherwise in the figure legend. The respective <italic>n</italic> values are shown in the figure legends. The mice used for bone marrow transplantation were randomized and no blinding protocol was used. No statistical method was used to pre-determine the sample sizes. The results were quantified using GraphPad Prism 8. Student’s t test was utilized to compare the differences between two groups. One-way ANOVA with Tukey’s or Bonferroni’s multiple comparison test was used to compare the differences among three or more groups. Two-way ANOVA with Bonferroni’s post test was used to calculate the significance for in vitro DN2 differentiation measurement over time.</p></sec><sec id="s4-20"><title>Study approval</title><p>All protocols described in this study were approved by the Baylor College of Medicine Institutional Animal Care and Use Committee (protocol: AN-6813) or Case Western Reserve University Institutional Animal Care and Use Committee (protocol: 2017–0055).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Juan Carlos Zúñiga-Pflücker (University of Toronto) for providing the OP9-DL1 cells and Dr. Laurie Glimcher (Dana Farber Cancer Institute) for providing the <italic>Xbp1</italic> flox mice. This work was supported by the Cytometry and Cell Sorting Core at the Baylor College of Medicine with funding from the CPRIT Core Facility Support Award (CPRIT-RP180672), the NIH (CA125123, S10OD025251 and RR024574) and the assistance of J M Sederstrom. Imaging for this work was supported by the Integrated Microscopy Core at Baylor College of Medicine and the Center for Advanced Microscopy and Image Informatics (CAMII) with funding from NIH (DK56338, CA125123, ES030285), and CPRIT (RP150578, RP170719), the Dan L Duncan Comprehensive Cancer Center, and the John S Dunn Gulf Coast Consortium for Chemical Genomics.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Methodology</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Validation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con10"><p>Resources</p></fn><fn fn-type="con" id="con11"><p>Resources</p></fn><fn fn-type="con" id="con12"><p>Resources</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Formal analysis, Supervision, Validation, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All protocols described in this study were approved by the Baylor College of Medicine Institutional Animal Care and Use Committee (protocol: AN-6813) or Case Western Reserve University Institutional Animal Care and Use Committee (protocol: 2017-0055).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69975-transrepform-v3.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE173993. All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all Figures.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Umphred-Wilson</surname><given-names>K</given-names></name><name><surname>Peng</surname><given-names>F</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Barton</surname><given-names>BM</given-names></name><name><surname>Lv</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>MY</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Adoro</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Notch-Induced Endoplasmic Reticulum-Associated Degradation Governs Thymocyte Beta-Selection</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE173993">GSE173993</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aster</surname> <given-names>JC</given-names></name><name><surname>Blacklow</surname> <given-names>SC</given-names></name><name><surname>Pear</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies</article-title><source>The Journal of Pathology</source><volume>223</volume><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1002/path.2789</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname> <given-names>M</given-names></name><name><surname>Doukas</surname> <given-names>M</given-names></name><name><surname>Papoudou-Bai</surname> <given-names>A</given-names></name><name><surname>Barbouti</surname> <given-names>A</given-names></name><name><surname>Stefanaki</surname> <given-names>K</given-names></name><name><surname>Galani</surname> <given-names>V</given-names></name><name><surname>Kanavaros</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Immunohistological analysis of cell cycle and apoptosis regulators in Thymus</article-title><source>Annals of Anatomy - Anatomischer Anzeiger</source><volume>195</volume><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.aanat.2012.07.012</pub-id><pub-id pub-id-type="pmid">23058459</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balchin</surname> <given-names>D</given-names></name><name><surname>Hayer-Hartl</surname> <given-names>M</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo aspects of protein folding and quality control</article-title><source>Science</source><volume>353</volume><elocation-id>aac4354</elocation-id><pub-id pub-id-type="doi">10.1126/science.aac4354</pub-id><pub-id pub-id-type="pmid">27365453</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balciunaite</surname> <given-names>G</given-names></name><name><surname>Ceredig</surname> <given-names>R</given-names></name><name><surname>Fehling</surname> <given-names>HJ</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name><name><surname>Rolink</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The role of notch and IL-7 signaling in early thymocyte proliferation and differentiation</article-title><source>European Journal of Immunology</source><volume>35</volume><fpage>1292</fpage><lpage>1300</lpage><pub-id pub-id-type="doi">10.1002/eji.200425822</pub-id><pub-id pub-id-type="pmid">15770699</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettigole</surname> <given-names>SE</given-names></name><name><surname>Lis</surname> <given-names>R</given-names></name><name><surname>Adoro</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>AH</given-names></name><name><surname>Spencer</surname> <given-names>LA</given-names></name><name><surname>Weller</surname> <given-names>PF</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The transcription factor XBP1 is selectively required for eosinophil differentiation</article-title><source>Nature Immunology</source><volume>16</volume><fpage>829</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/ni.3225</pub-id><pub-id pub-id-type="pmid">26147683</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Notch signalling in context</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>17</volume><fpage>722</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.94</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodsky</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cleaning up: er-associated degradation to the rescue</article-title><source>Cell</source><volume>151</volume><fpage>1163</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.11.012</pub-id><pub-id pub-id-type="pmid">23217703</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryksin</surname> <given-names>AV</given-names></name><name><surname>Matsumura</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids</article-title><source>BioTechniques</source><volume>48</volume><fpage>463</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.2144/000113418</pub-id><pub-id pub-id-type="pmid">20569222</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camelo</surname> <given-names>S</given-names></name><name><surname>Raoul</surname> <given-names>W</given-names></name><name><surname>Lavalette</surname> <given-names>S</given-names></name><name><surname>Calippe</surname> <given-names>B</given-names></name><name><surname>Cristofaro</surname> <given-names>B</given-names></name><name><surname>Levy</surname> <given-names>O</given-names></name><name><surname>Houssier</surname> <given-names>M</given-names></name><name><surname>Sulpice</surname> <given-names>E</given-names></name><name><surname>Jonet</surname> <given-names>L</given-names></name><name><surname>Klein</surname> <given-names>C</given-names></name><name><surname>Devevre</surname> <given-names>E</given-names></name><name><surname>Thuret</surname> <given-names>G</given-names></name><name><surname>Duarte</surname> <given-names>A</given-names></name><name><surname>Eichmann</surname> <given-names>A</given-names></name><name><surname>Leconte</surname> <given-names>L</given-names></name><name><surname>Guillonneau</surname> <given-names>X</given-names></name><name><surname>Sennlaub</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages</article-title><source>Angiogenesis</source><volume>15</volume><fpage>609</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1007/s10456-012-9290-0</pub-id><pub-id pub-id-type="pmid">22869002</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname> <given-names>AC</given-names></name><name><surname>Bosselut</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Decision checkpoints in the Thymus</article-title><source>Nature Immunology</source><volume>11</volume><fpage>666</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1038/ni.1887</pub-id><pub-id pub-id-type="pmid">20644572</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castel</surname> <given-names>D</given-names></name><name><surname>Mourikis</surname> <given-names>P</given-names></name><name><surname>Bartels</surname> <given-names>SJ</given-names></name><name><surname>Brinkman</surname> <given-names>AB</given-names></name><name><surname>Tajbakhsh</surname> <given-names>S</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dynamic binding of RBPJ is determined by notch signaling status</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1059</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1101/gad.211912.112</pub-id><pub-id pub-id-type="pmid">23651858</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>MZ</given-names></name><name><surname>Moily</surname> <given-names>NS</given-names></name><name><surname>Bridgford</surname> <given-names>JL</given-names></name><name><surname>Wood</surname> <given-names>RJ</given-names></name><name><surname>Radwan</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>TA</given-names></name><name><surname>Song</surname> <given-names>Z</given-names></name><name><surname>Tang</surname> <given-names>BZ</given-names></name><name><surname>Tilley</surname> <given-names>L</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Reid</surname> <given-names>GE</given-names></name><name><surname>Pouladi</surname> <given-names>MA</given-names></name><name><surname>Hong</surname> <given-names>Y</given-names></name><name><surname>Hatters</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A thiol probe for measuring unfolded protein load and proteostasis in cells</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>474</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00203-5</pub-id><pub-id pub-id-type="pmid">28883394</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>ELY</given-names></name><name><surname>Thompson</surname> <given-names>PK</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RBPJ-dependent notch signaling initiates the T cell program in a subset of thymus-seeding progenitors</article-title><source>Nature Immunology</source><volume>20</volume><fpage>1456</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0518-7</pub-id><pub-id pub-id-type="pmid">31636466</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciofani</surname> <given-names>M</given-names></name><name><surname>Schmitt</surname> <given-names>TM</given-names></name><name><surname>Ciofani</surname> <given-names>A</given-names></name><name><surname>Michie</surname> <given-names>AM</given-names></name><name><surname>Cuburu</surname> <given-names>N</given-names></name><name><surname>Aublin</surname> <given-names>A</given-names></name><name><surname>Maryanski</surname> <given-names>JL</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Obligatory role for cooperative signaling by pre-TCR and notch during thymocyte differentiation</article-title><source>The Journal of Immunology</source><volume>172</volume><fpage>5230</fpage><lpage>5239</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.9.5230</pub-id><pub-id pub-id-type="pmid">15100261</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciofani</surname> <given-names>M</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism</article-title><source>Nature Immunology</source><volume>6</volume><fpage>881</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1038/ni1234</pub-id><pub-id pub-id-type="pmid">16056227</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>D</given-names></name><name><surname>Raeburn</surname> <given-names>C</given-names></name><name><surname>Sui</surname> <given-names>X</given-names></name><name><surname>Hatters</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protein aggregation in cell biology: an aggregomics perspective of health and disease</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>99</volume><fpage>40</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2018.05.003</pub-id><pub-id pub-id-type="pmid">29753879</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cubillos-Ruiz</surname> <given-names>JR</given-names></name><name><surname>Silberman</surname> <given-names>PC</given-names></name><name><surname>Rutkowski</surname> <given-names>MR</given-names></name><name><surname>Chopra</surname> <given-names>S</given-names></name><name><surname>Perales-Puchalt</surname> <given-names>A</given-names></name><name><surname>Song</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Bettigole</surname> <given-names>SE</given-names></name><name><surname>Gupta</surname> <given-names>D</given-names></name><name><surname>Holcomb</surname> <given-names>K</given-names></name><name><surname>Ellenson</surname> <given-names>LH</given-names></name><name><surname>Caputo</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>AH</given-names></name><name><surname>Conejo-Garcia</surname> <given-names>JR</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ER stress sensor XBP1 controls Anti-tumor immunity by disrupting dendritic cell homeostasis</article-title><source>Cell</source><volume>161</volume><fpage>1527</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.025</pub-id><pub-id pub-id-type="pmid">26073941</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Obaldia</surname> <given-names>ME</given-names></name><name><surname>Bell</surname> <given-names>JJ</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Harly</surname> <given-names>C</given-names></name><name><surname>Yashiro-Ohtani</surname> <given-names>Y</given-names></name><name><surname>DeLong</surname> <given-names>JH</given-names></name><name><surname>Zlotoff</surname> <given-names>DA</given-names></name><name><surname>Sultana</surname> <given-names>DA</given-names></name><name><surname>Pear</surname> <given-names>WS</given-names></name><name><surname>Bhandoola</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>T cell development requires constraint of the myeloid regulator C/EBP-α by the notch target and transcriptional repressor Hes1</article-title><source>Nature Immunology</source><volume>14</volume><fpage>1277</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1038/ni.2760</pub-id><pub-id pub-id-type="pmid">24185616</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>H</given-names></name><name><surname>Adams</surname> <given-names>NM</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Cao</surname> <given-names>J</given-names></name><name><surname>Allan</surname> <given-names>DSJ</given-names></name><name><surname>Carlyle</surname> <given-names>JR</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Sun</surname> <given-names>JC</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc</article-title><source>Nature Immunology</source><volume>20</volume><fpage>865</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0388-z</pub-id><pub-id pub-id-type="pmid">31086333</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feige</surname> <given-names>MJ</given-names></name><name><surname>Behnke</surname> <given-names>J</given-names></name><name><surname>Mittag</surname> <given-names>T</given-names></name><name><surname>Hendershot</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dimerization-dependent folding underlies assembly control of the clonotypic αβt cell receptor chains</article-title><source>Journal of Biological Chemistry</source><volume>290</volume><fpage>26821</fpage><lpage>26831</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.689471</pub-id><pub-id pub-id-type="pmid">26400083</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feige</surname> <given-names>MJ</given-names></name><name><surname>Hendershot</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Quality control of integral membrane proteins by assembly-dependent membrane integration</article-title><source>Molecular Cell</source><volume>51</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.07.013</pub-id><pub-id pub-id-type="pmid">23932713</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname> <given-names>K</given-names></name><name><surname>Greenwald</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Interchangeability of Caenorhabditis elegans DSL proteins and intrinsic signalling activity of their extracellular domains in vivo</article-title><source>Development</source><volume>121</volume><fpage>4275</fpage><lpage>4282</lpage><pub-id pub-id-type="doi">10.1242/dev.121.12.4275</pub-id><pub-id pub-id-type="pmid">8575327</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Peydró</surname> <given-names>M</given-names></name><name><surname>Fuentes</surname> <given-names>P</given-names></name><name><surname>Mosquera</surname> <given-names>M</given-names></name><name><surname>García-León</surname> <given-names>MJ</given-names></name><name><surname>Alcain</surname> <given-names>J</given-names></name><name><surname>Rodríguez</surname> <given-names>A</given-names></name><name><surname>García de Miguel</surname> <given-names>P</given-names></name><name><surname>Menéndez</surname> <given-names>P</given-names></name><name><surname>Weijer</surname> <given-names>K</given-names></name><name><surname>Spits</surname> <given-names>H</given-names></name><name><surname>Scadden</surname> <given-names>DT</given-names></name><name><surname>Cuesta-Mateos</surname> <given-names>C</given-names></name><name><surname>Muñoz-Calleja</surname> <given-names>C</given-names></name><name><surname>Sánchez-Madrid</surname> <given-names>F</given-names></name><name><surname>Toribio</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The NOTCH1/CD44 Axis drives pathogenesis in a T cell acute lymphoblastic leukemia model</article-title><source>Journal of Clinical Investigation</source><volume>128</volume><fpage>2802</fpage><lpage>2818</lpage><pub-id pub-id-type="doi">10.1172/JCI92981</pub-id><pub-id pub-id-type="pmid">29781813</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gegonne</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>QR</given-names></name><name><surname>Dey</surname> <given-names>A</given-names></name><name><surname>Etzensperger</surname> <given-names>R</given-names></name><name><surname>Tai</surname> <given-names>X</given-names></name><name><surname>Singer</surname> <given-names>A</given-names></name><name><surname>Meerzaman</surname> <given-names>D</given-names></name><name><surname>Ozato</surname> <given-names>K</given-names></name><name><surname>Singer</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Immature CD8 Single-Positive thymocytes are a molecularly distinct subpopulation, selectively dependent on BRD4 for their differentiation</article-title><source>Cell Reports</source><volume>24</volume><fpage>117</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.06.007</pub-id><pub-id pub-id-type="pmid">29972774</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname> <given-names>C</given-names></name><name><surname>Martinon</surname> <given-names>F</given-names></name><name><surname>Rodriguez</surname> <given-names>D</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The unfolded protein response: integrating stress signals through the stress sensor IRE1α</article-title><source>Physiological Reviews</source><volume>91</volume><fpage>1219</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1152/physrev.00001.2011</pub-id><pub-id pub-id-type="pmid">22013210</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidalgo San Jose</surname> <given-names>L</given-names></name><name><surname>Sunshine</surname> <given-names>MJ</given-names></name><name><surname>Dillingham</surname> <given-names>CH</given-names></name><name><surname>Chua</surname> <given-names>BA</given-names></name><name><surname>Kruta</surname> <given-names>M</given-names></name><name><surname>Hong</surname> <given-names>Y</given-names></name><name><surname>Hatters</surname> <given-names>DM</given-names></name><name><surname>Signer</surname> <given-names>RAJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Modest declines in proteome quality impair hematopoietic stem cell Self-Renewal</article-title><source>Cell Reports</source><volume>30</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.12.003</pub-id><pub-id pub-id-type="pmid">31914399</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidalgo San Jose</surname> <given-names>L</given-names></name><name><surname>Signer</surname> <given-names>RAJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cell-type-specific quantification of protein synthesis in vivo</article-title><source>Nature Protocols</source><volume>14</volume><fpage>441</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/s41596-018-0100-z</pub-id><pub-id pub-id-type="pmid">30610239</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname> <given-names>R</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro</article-title><source>Cold Spring Harbor Protocols</source><volume>2009</volume><elocation-id>pdb.prot5156</elocation-id><pub-id pub-id-type="doi">10.1101/pdb.prot5156</pub-id><pub-id pub-id-type="pmid">20147086</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>J</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Quality control in the endoplasmic reticulum: crosstalk between ERAD and UPR pathways</article-title><source>Trends in Biochemical Sciences</source><volume>43</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2018.06.005</pub-id><pub-id pub-id-type="pmid">30056836</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwakoshi</surname> <given-names>NN</given-names></name><name><surname>Pypaert</surname> <given-names>M</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The transcription factor XBP-1 is essential for the development and survival of dendritic cells</article-title><source>Journal of Experimental Medicine</source><volume>204</volume><fpage>2267</fpage><lpage>2275</lpage><pub-id pub-id-type="doi">10.1084/jem.20070525</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Sha</surname> <given-names>H</given-names></name><name><surname>Roman</surname> <given-names>CA</given-names></name><name><surname>Long</surname> <given-names>Q</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Sel1L-Hrd1 endoplasmic Reticulum-Associated degradation complex manages a key checkpoint in B cell development</article-title><source>Cell Reports</source><volume>16</volume><fpage>2630</fpage><lpage>2640</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.003</pub-id><pub-id pub-id-type="pmid">27568564</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname> <given-names>C</given-names></name><name><surname>Quach</surname> <given-names>JM</given-names></name><name><surname>Walkley</surname> <given-names>CR</given-names></name><name><surname>Lane</surname> <given-names>SW</given-names></name><name><surname>Lo Celso</surname> <given-names>C</given-names></name><name><surname>Purton</surname> <given-names>LE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies</article-title><source>Cell Stem Cell</source><volume>13</volume><fpage>520</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2013.10.010</pub-id><pub-id pub-id-type="pmid">24209759</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadakia</surname> <given-names>T</given-names></name><name><surname>Tai</surname> <given-names>X</given-names></name><name><surname>Kruhlak</surname> <given-names>M</given-names></name><name><surname>Wisniewski</surname> <given-names>J</given-names></name><name><surname>Hwang</surname> <given-names>I-Y</given-names></name><name><surname>Roy</surname> <given-names>S</given-names></name><name><surname>Guinter</surname> <given-names>TI</given-names></name><name><surname>Alag</surname> <given-names>A</given-names></name><name><surname>Kehrl</surname> <given-names>JH</given-names></name><name><surname>Zhuang</surname> <given-names>Y</given-names></name><name><surname>Singer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>E-protein–regulated expression of CXCR4 adheres preselection thymocytes to the thymic cortex</article-title><source>Journal of Experimental Medicine</source><volume>216</volume><fpage>1749</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1084/jem.20182285</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>SK</given-names></name><name><surname>Jeon</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Jeon</surname> <given-names>SH</given-names></name><name><surname>Shim</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>IH</given-names></name><name><surname>Hong</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>N</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Seong</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>TopBP1 deficiency impairs V(D)J recombination during lymphocyte development</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>n/a</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1002/embj.201284316</pub-id><pub-id pub-id-type="pmid">24442639</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreslavsky</surname> <given-names>T</given-names></name><name><surname>Gleimer</surname> <given-names>M</given-names></name><name><surname>Miyazaki</surname> <given-names>M</given-names></name><name><surname>Choi</surname> <given-names>Y</given-names></name><name><surname>Gagnon</surname> <given-names>E</given-names></name><name><surname>Murre</surname> <given-names>C</given-names></name><name><surname>Sicinski</surname> <given-names>P</given-names></name><name><surname>von Boehmer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>β-Selection-induced proliferation is required for αβ T cell differentiation</article-title><source>Immunity</source><volume>37</volume><fpage>840</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.08.020</pub-id><pub-id pub-id-type="pmid">23159226</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maillard</surname> <given-names>I</given-names></name><name><surname>Tu</surname> <given-names>L</given-names></name><name><surname>Sambandam</surname> <given-names>A</given-names></name><name><surname>Yashiro-Ohtani</surname> <given-names>Y</given-names></name><name><surname>Millholland</surname> <given-names>J</given-names></name><name><surname>Keeshan</surname> <given-names>K</given-names></name><name><surname>Shestova</surname> <given-names>O</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Bhandoola</surname> <given-names>A</given-names></name><name><surname>Pear</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The requirement for notch signaling at the β-selection checkpoint in vivo is absolute and independent of the pre–T cell receptor</article-title><source>Journal of Experimental Medicine</source><volume>203</volume><fpage>2239</fpage><lpage>2245</lpage><pub-id pub-id-type="doi">10.1084/jem.20061020</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallick</surname> <given-names>CA</given-names></name><name><surname>Dudley</surname> <given-names>EC</given-names></name><name><surname>Viney</surname> <given-names>JL</given-names></name><name><surname>Owen</surname> <given-names>MJ</given-names></name><name><surname>Hayday</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Rearrangement and diversity of T cell receptor beta chain genes in thymocytes: a critical role for the beta chain in development</article-title><source>Cell</source><volume>73</volume><fpage>513</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90138-G</pub-id><pub-id pub-id-type="pmid">8387894</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquis</surname> <given-names>M</given-names></name><name><surname>Daudelin</surname> <given-names>JF</given-names></name><name><surname>Boulet</surname> <given-names>S</given-names></name><name><surname>Sirois</surname> <given-names>J</given-names></name><name><surname>Crain</surname> <given-names>K</given-names></name><name><surname>Mathien</surname> <given-names>S</given-names></name><name><surname>Turgeon</surname> <given-names>B</given-names></name><name><surname>Rousseau</surname> <given-names>J</given-names></name><name><surname>Meloche</surname> <given-names>S</given-names></name><name><surname>Labrecque</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The catalytic activity of the mitogen-activated protein kinase extracellular signal-regulated kinase 3 is required to sustain CD4+ CD8+ thymocyte survival</article-title><source>Molecular and Cellular Biology</source><volume>34</volume><fpage>3374</fpage><lpage>3387</lpage><pub-id pub-id-type="doi">10.1128/MCB.01701-13</pub-id><pub-id pub-id-type="pmid">25002529</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michie</surname> <given-names>AM</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Regulation of thymocyte differentiation: pre-tcr signals and beta-selection</article-title><source>Seminars in Immunology</source><volume>14</volume><fpage>311</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/S1044-5323(02)00064-7</pub-id><pub-id pub-id-type="pmid">12220932</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagelreiter</surname> <given-names>F</given-names></name><name><surname>Coats</surname> <given-names>MT</given-names></name><name><surname>Klanert</surname> <given-names>G</given-names></name><name><surname>Gludovacz</surname> <given-names>E</given-names></name><name><surname>Borth</surname> <given-names>N</given-names></name><name><surname>Grillari</surname> <given-names>J</given-names></name><name><surname>Schosserer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>OPP labeling enables total protein synthesis quantification in CHO production cell lines at the Single-Cell level</article-title><source>Biotechnology Journal</source><volume>13</volume><elocation-id>1700492</elocation-id><pub-id pub-id-type="doi">10.1002/biot.201700492</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatsukasa</surname> <given-names>K</given-names></name><name><surname>Brodsky</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum</article-title><source>Traffic</source><volume>9</volume><fpage>861</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2008.00729.x</pub-id><pub-id pub-id-type="pmid">18315532</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osorio</surname> <given-names>F</given-names></name><name><surname>Tavernier</surname> <given-names>SJ</given-names></name><name><surname>Hoffmann</surname> <given-names>E</given-names></name><name><surname>Saeys</surname> <given-names>Y</given-names></name><name><surname>Martens</surname> <given-names>L</given-names></name><name><surname>Vetters</surname> <given-names>J</given-names></name><name><surname>Delrue</surname> <given-names>I</given-names></name><name><surname>De Rycke</surname> <given-names>R</given-names></name><name><surname>Parthoens</surname> <given-names>E</given-names></name><name><surname>Pouliot</surname> <given-names>P</given-names></name><name><surname>Iwawaki</surname> <given-names>T</given-names></name><name><surname>Janssens</surname> <given-names>S</given-names></name><name><surname>Lambrecht</surname> <given-names>BN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The unfolded-protein-response sensor IRE-1α regulates the function of CD8α+ dendritic cells</article-title><source>Nature Immunology</source><volume>15</volume><fpage>248</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1038/ni.2808</pub-id><pub-id pub-id-type="pmid">24441789</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname> <given-names>L</given-names></name><name><surname>Tsai</surname> <given-names>B</given-names></name><name><surname>Arvan</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>New insights into the physiological role of endoplasmic Reticulum-Associated degradation</article-title><source>Trends in Cell Biology</source><volume>27</volume><fpage>430</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2016.12.002</pub-id><pub-id pub-id-type="pmid">28131647</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimold</surname> <given-names>AM</given-names></name><name><surname>Iwakoshi</surname> <given-names>NN</given-names></name><name><surname>Manis</surname> <given-names>J</given-names></name><name><surname>Vallabhajosyula</surname> <given-names>P</given-names></name><name><surname>Szomolanyi-Tsuda</surname> <given-names>E</given-names></name><name><surname>Gravallese</surname> <given-names>EM</given-names></name><name><surname>Friend</surname> <given-names>D</given-names></name><name><surname>Grusby</surname> <given-names>MJ</given-names></name><name><surname>Alt</surname> <given-names>F</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Plasma cell differentiation requires the transcription factor XBP-1</article-title><source>Nature</source><volume>412</volume><fpage>300</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1038/35085509</pub-id><pub-id pub-id-type="pmid">11460154</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggiano</surname> <given-names>A</given-names></name><name><surname>Foresti</surname> <given-names>O</given-names></name><name><surname>Carvalho</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ER-associated degradation: protein quality control and beyond</article-title><source>Journal of Cell Biology</source><volume>204</volume><fpage>869</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1083/jcb.201312042</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambandam</surname> <given-names>A</given-names></name><name><surname>Maillard</surname> <given-names>I</given-names></name><name><surname>Zediak</surname> <given-names>VP</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Gerstein</surname> <given-names>RM</given-names></name><name><surname>Aster</surname> <given-names>JC</given-names></name><name><surname>Pear</surname> <given-names>WS</given-names></name><name><surname>Bhandoola</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Notch signaling controls the generation and differentiation of early T lineage progenitors</article-title><source>Nature Immunology</source><volume>6</volume><fpage>663</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1038/ni1216</pub-id><pub-id pub-id-type="pmid">15951813</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname> <given-names>TM</given-names></name><name><surname>de Pooter</surname> <given-names>RF</given-names></name><name><surname>Gronski</surname> <given-names>MA</given-names></name><name><surname>Cho</surname> <given-names>SK</given-names></name><name><surname>Ohashi</surname> <given-names>PS</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro</article-title><source>Nature Immunology</source><volume>5</volume><fpage>410</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1038/ni1055</pub-id><pub-id pub-id-type="pmid">15034575</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>DK</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An overview of the intrathymic intricacies of T cell development</article-title><source>The Journal of Immunology</source><volume>192</volume><fpage>4017</fpage><lpage>4023</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302259</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro-Shelef</surname> <given-names>M</given-names></name><name><surname>Calame</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Regulation of plasma-cell development</article-title><source>Nature Reviews Immunology</source><volume>5</volume><fpage>230</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1038/nri1572</pub-id><pub-id pub-id-type="pmid">15738953</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Petrie</surname> <given-names>HT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Activation kinetics and off-target effects of thymus-initiated cre transgenes</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e46590</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0046590</pub-id><pub-id pub-id-type="pmid">23049709</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegemund</surname> <given-names>S</given-names></name><name><surname>Shepherd</surname> <given-names>J</given-names></name><name><surname>Xiao</surname> <given-names>C</given-names></name><name><surname>Sauer</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>hCD2-iCre and Vav-iCre mediated gene recombination patterns in murine hematopoietic cells</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0124661</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0124661</pub-id><pub-id pub-id-type="pmid">25884630</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Shi</surname> <given-names>G</given-names></name><name><surname>Han</surname> <given-names>X</given-names></name><name><surname>Francisco</surname> <given-names>AB</given-names></name><name><surname>Ji</surname> <given-names>Y</given-names></name><name><surname>Mendonça</surname> <given-names>N</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name><name><surname>Simpson</surname> <given-names>KW</given-names></name><name><surname>Duhamel</surname> <given-names>GE</given-names></name><name><surname>Kersten</surname> <given-names>S</given-names></name><name><surname>Yates</surname> <given-names>JR</given-names></name><name><surname>Long</surname> <given-names>Q</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sel1L is indispensable for mammalian endoplasmic reticulum-associated degradation, endoplasmic reticulum homeostasis, and survival</article-title><source>PNAS</source><volume>111</volume><fpage>E582</fpage><lpage>E591</lpage><pub-id pub-id-type="doi">10.1073/pnas.1318114111</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahama</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Journey through the Thymus: stromal guides for T-cell development and selection</article-title><source>Nature Reviews Immunology</source><volume>6</volume><fpage>127</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/nri1781</pub-id><pub-id pub-id-type="pmid">16491137</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanigaki</surname> <given-names>K</given-names></name><name><surname>Honjo</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of lymphocyte development by notch signaling</article-title><source>Nature Immunology</source><volume>8</volume><fpage>451</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1038/ni1453</pub-id><pub-id pub-id-type="pmid">17440450</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname> <given-names>M</given-names></name><name><surname>Suttapitugsakul</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Effective method for accurate and sensitive quantitation of rapid changes of newly synthesized proteins</article-title><source>Analytical Chemistry</source><volume>92</volume><fpage>10048</fpage><lpage>10057</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.0c01823</pub-id><pub-id pub-id-type="pmid">32531160</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trampont</surname> <given-names>PC</given-names></name><name><surname>Tosello-Trampont</surname> <given-names>AC</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Duley</surname> <given-names>AK</given-names></name><name><surname>Sutherland</surname> <given-names>AE</given-names></name><name><surname>Bender</surname> <given-names>TP</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Ravichandran</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CXCR4 acts as a costimulator during thymic beta-selection</article-title><source>Nature Immunology</source><volume>11</volume><fpage>162</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1038/ni.1830</pub-id><pub-id pub-id-type="pmid">20010845</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Boomen</surname> <given-names>DJ</given-names></name><name><surname>Lehner</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I</article-title><source>Molecular Immunology</source><volume>68</volume><fpage>106</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2015.07.005</pub-id><pub-id pub-id-type="pmid">26210183</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Freeden-Jeffry</surname> <given-names>U</given-names></name><name><surname>Solvason</surname> <given-names>N</given-names></name><name><surname>Howard</surname> <given-names>M</given-names></name><name><surname>Murray</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The earliest T Lineage–Committed Cells Depend on IL-7 for Bcl-2 Expression and Normal Cell Cycle Progression</article-title><source>Immunity</source><volume>7</volume><fpage>147</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(00)80517-8</pub-id><pub-id pub-id-type="pmid">9252127</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname> <given-names>P</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The unfolded protein response: from stress pathway to homeostatic regulation</article-title><source>Science</source><volume>334</volume><fpage>1081</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1126/science.1209038</pub-id><pub-id pub-id-type="pmid">22116877</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Yi</surname> <given-names>P</given-names></name><name><surname>Dong</surname> <given-names>W</given-names></name><name><surname>Nalin</surname> <given-names>AP</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>Z</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Benson</surname> <given-names>DM</given-names></name><name><surname>Mundy-Bosse</surname> <given-names>BL</given-names></name><name><surname>Freud</surname> <given-names>AG</given-names></name><name><surname>Caligiuri</surname> <given-names>MA</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells</article-title><source>Nature Immunology</source><volume>20</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0265-1</pub-id><pub-id pub-id-type="pmid">30538328</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname> <given-names>AP</given-names></name><name><surname>Ferrando</surname> <given-names>AA</given-names></name><name><surname>Lee</surname> <given-names>W</given-names></name><name><surname>Morris</surname> <given-names>JP</given-names></name><name><surname>Silverman</surname> <given-names>LB</given-names></name><name><surname>Sanchez-Irizarry</surname> <given-names>C</given-names></name><name><surname>Blacklow</surname> <given-names>SC</given-names></name><name><surname>Look</surname> <given-names>AT</given-names></name><name><surname>Aster</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Activating mutations of <italic>NOTCH1</italic> in human T cell acute lymphoblastic leukemia</article-title><source>Science</source><volume>306</volume><fpage>269</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1126/science.1102160</pub-id><pub-id pub-id-type="pmid">15472075</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>F</given-names></name><name><surname>Qiu</surname> <given-names>Q</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Kong</surname> <given-names>Q</given-names></name><name><surname>Gao</surname> <given-names>B</given-names></name><name><surname>Melo-Cardenas</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>DD</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Fang</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12073</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12073</pub-id><pub-id pub-id-type="pmid">27417417</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Peng</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Ding</surname> <given-names>Y</given-names></name><name><surname>Gu</surname> <given-names>T</given-names></name><name><surname>Lv</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Ortinau</surname> <given-names>L</given-names></name><name><surname>Hu</surname> <given-names>T</given-names></name><name><surname>Shi</surname> <given-names>X</given-names></name><name><surname>Shi</surname> <given-names>G</given-names></name><name><surname>Shang</surname> <given-names>G</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Iwawaki</surname> <given-names>T</given-names></name><name><surname>Ji</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Rosen</surname> <given-names>JM</given-names></name><name><surname>Zhang</surname> <given-names>XH</given-names></name><name><surname>Park</surname> <given-names>D</given-names></name><name><surname>Adoro</surname> <given-names>S</given-names></name><name><surname>Catic</surname> <given-names>A</given-names></name><name><surname>Tong</surname> <given-names>W</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name><name><surname>Nakada</surname> <given-names>D</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>1162</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-00581-x</pub-id><pub-id pub-id-type="pmid">32958856</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname> <given-names>S</given-names></name><name><surname>Ishikawa</surname> <given-names>E</given-names></name><name><surname>Sakuma</surname> <given-names>M</given-names></name><name><surname>Ogata</surname> <given-names>K</given-names></name><name><surname>Sakata-Sogawa</surname> <given-names>K</given-names></name><name><surname>Hiroshima</surname> <given-names>M</given-names></name><name><surname>Wiest</surname> <given-names>DL</given-names></name><name><surname>Tokunaga</surname> <given-names>M</given-names></name><name><surname>Saito</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development</article-title><source>Nature Immunology</source><volume>7</volume><fpage>67</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1038/ni1290</pub-id><pub-id pub-id-type="pmid">16327787</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Kong</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Melo-Cardenas</surname> <given-names>J</given-names></name><name><surname>Gao</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>DD</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Thorp</surname> <given-names>E</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Fang</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice</article-title><source>Journal of Biological Chemistry</source><volume>293</volume><fpage>12934</fpage><lpage>12944</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA117.001267</pub-id><pub-id pub-id-type="pmid">29907570</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>N</given-names></name><name><surname>Cao</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Tang</surname> <given-names>Q</given-names></name><name><surname>Dobrolecki</surname> <given-names>LE</given-names></name><name><surname>Lv</surname> <given-names>X</given-names></name><name><surname>Talukdar</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Hu</surname> <given-names>DZ</given-names></name><name><surname>Shi</surname> <given-names>Q</given-names></name><name><surname>Xiang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Bu</surname> <given-names>W</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>Z</given-names></name><name><surname>Ying</surname> <given-names>H</given-names></name><name><surname>Yuan</surname> <given-names>B</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Feng</surname> <given-names>XH</given-names></name><name><surname>Hartig</surname> <given-names>SM</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Han</surname> <given-names>L</given-names></name><name><surname>Zeng</surname> <given-names>Q</given-names></name><name><surname>Patterson</surname> <given-names>JB</given-names></name><name><surname>Kaipparettu</surname> <given-names>BA</given-names></name><name><surname>Putluri</surname> <given-names>N</given-names></name><name><surname>Sicheri</surname> <given-names>F</given-names></name><name><surname>Rosen</surname> <given-names>JM</given-names></name><name><surname>Lewis</surname> <given-names>MT</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast Cancer</article-title><source>Journal of Clinical Investigation</source><volume>128</volume><fpage>1283</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1172/JCI95873</pub-id><pub-id pub-id-type="pmid">29480818</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>B</given-names></name><name><surname>Yoganathan</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Lee</surname> <given-names>JY</given-names></name><name><surname>Zúñiga-Pflücker</surname> <given-names>JC</given-names></name><name><surname>Love</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12</article-title><source>Nature Immunology</source><volume>20</volume><fpage>1381</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0469-z</pub-id><pub-id pub-id-type="pmid">31451788</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><boxed-text><table-wrap id="keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Sel1l</italic><sup>flox</sup></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24453213">24453213</ext-link></td><td valign="top"/><td valign="top">Dr. Ling Qi (Department of Molecular and Integrative Physiology, University of Michigan Medical School)</td></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Xbp1<sup>flox</sup></italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18556558">18556558</ext-link></td><td valign="top"/><td valign="top">Dr. Laurie H. Glimcher (Dana Farber Cancer Institute)</td></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Perk<sup>flox</sup></italic></td><td valign="top">Jackson Laboratory</td><td valign="top">Stock No. 023066 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:023066">IMSR_JAX:023066</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top">h<italic>CD2-iCre</italic></td><td valign="top">Jackson Laboratory</td><td valign="top">Stock No. 008520 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:008520">IMSR_JAX:008520</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Cd4-Cre</italic></td><td valign="top">Jackson Laboratory</td><td valign="top">Stock No. 022071 RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:022071">IMSR_JAX:022071</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Atf6l<sup>flox</sup></italic></td><td valign="top">Jackson Laboratory</td><td valign="top">Stock No. 028253 RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:028253">IMSR_JAX:028253</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Vav1-iCre</italic></td><td valign="top">Jackson Laboratory</td><td valign="top">Stock No. 008610 RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:008610">IMSR_JAX:008610</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top">OTII transgenic</td><td valign="top">Jackson Laboratory</td><td valign="top">Stock No. 004194 RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:004194">IMSR_JAX:004194</ext-link></td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>M. musculus</italic>)</td><td valign="top">EL4</td><td valign="top">ATCC</td><td valign="top">TIB-39 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0255">CVCL_0255</ext-link></td><td valign="top"/></tr><tr><td valign="top">Cell line (<italic>M. musculus</italic>)</td><td valign="top">OP9-DL1</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12479821">12479821</ext-link></td><td valign="top"/><td valign="top">Dr. Juan Carlos Zúñiga-Pflücker (University of Toronto)</td></tr><tr><td valign="top">Cell line (<italic>Homo sapiens</italic>)</td><td valign="top">HEK293T</td><td valign="top">ATCC</td><td valign="top">CRL-3216 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0063">CVCL_0063</ext-link></td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">FITC anti-mouse CD45.1, Clone A20 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">110706 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313494">AB_313494</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">APC anti-mouse CD45.2, Clone 104 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">109814 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_389211">AB_389211</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Pacific Blue anti-mouse CD45.1, Clone A20 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">110721 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_492867">AB_492867</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 700 anti-mouse CD45.2, Clone 104 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">109822 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493731">AB_493731</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">FITC anti-mouse/human CD44, Clone IM7 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">103006 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312957">AB_312957</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE/Dazzle 594 anti-mouse/human CD44, Clone IM7 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">103056 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2564044">AB_2564044</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">APC anti-mouse CD25, Clone 3C7 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">101910 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2280288">AB_2280288</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">FITC anti-mouse Ki-67, Clone 16A8 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">652409 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2562140">AB_2562140</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">APC/Fire 750 anti-mouse CD117 (c-Kit), Clone 2B8 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">105838 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2616739">AB_2616739</ext-link></td><td valign="top">(1:50) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Brilliant Violet 650 anti-mouse CD4, Clone RM4-5 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">100546 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2562098">AB_2562098</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 700 anti-mouse CD8a, Clone 53–6.7 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">100730 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493703">AB_493703</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE anti-mouse/rat/human CD27, Clone <break/>LG.3A10 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">124209 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1236464">AB_1236464</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE anti-mouse TCR β chain, Clone H57-597 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">109207 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313430">AB_313430</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">APC anti-mouse TCR β chain, Clone H57-598 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">109211 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313434">AB_313434</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE/Cyanine7 anti-mouse CD24, Clone M1/69 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">101822 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_756048">AB_756048</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE/Dazzle 594 anti-mouse CD3ε, Clone 145–2 C11 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">100348 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2564029">AB_2564029</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Pacific Blue anti-mouse/human CD45R/B220, Clone RA3-6B2 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">103230 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_492877">AB_492877</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">FITC anti-mouse NK-1.1, Clone PK136 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">108706 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313393">AB_313393</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">APC Anti-mouse TCR γ/δ, Clone GL3 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">118115 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1731824">AB_1731824</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE Anti-mouse TCR γ/δ, Clone GL3 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">118108 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313832">AB_313832</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE anti-mouse Notch 1, Clone HMN1-12 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">130607 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1227719">AB_1227719</ext-link></td><td valign="top">5 µL/test FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">violetFluor 450 Anti-Mouse CD45, Clone 30-F11 (Rat monoclonal)</td><td valign="top">TONBO</td><td valign="top">75–0451 U100 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2621947">AB_2621947</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE anti-mouse CD150 (SLAM), Clone TC15-12F12.2 (Rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">115904 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313683">AB_313683</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">TruStain FcX (anti-mouse CD16/32), Clone 93 (Rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">101320 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1574975">AB_1574975</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">APC anti-mouse Ly-6A/E (Sca-1), Clone D7 (Rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">108112 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313349">AB_313349</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE/Cyanine7 Streptavidin</td><td valign="top">BioLegend</td><td valign="top">405206</td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">FITC anti-mouse CD48, Clone HM48-1 (Armenian Hamster monoclonal)</td><td valign="top">BioLegend</td><td valign="top">103404 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313019">AB_313019</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotin anti-mouse CD3ε, Clone 145–2 C11 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">100304 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312669">AB_312669</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotin anti-mouse/human CD45R/B220, Clone RA3-6B2 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">103204 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312989">AB_312989</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotin anti-mouse TER-119, Clone TER-119 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">116204 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313705">AB_313705</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotin anti-mouse CD49b (pan-NK cells), Clone DX5 (Rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">108904 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313411">AB_313411</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotin anti-mouse/human CD11b, Clone M1/70 (Rat monoclonal)</td><td valign="top">Biolegend</td><td valign="top">101204 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312787">AB_312787</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotin anti-mouse CD11c, Clone N418 (Armenian Hamster monoclonal)</td><td valign="top">Biolegend</td><td valign="top">117303 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313772">AB_313772</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotin anti-mouse Ly-6G/Ly-6C (Gr-1), Clone RB6-8C5 (Rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">108404 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313369">AB_313369</ext-link></td><td valign="top">(1:100) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">FITC Mouse IgG1, κ Isotype Ctrl, Clone MOPC-21 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">400108 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_326429">AB_326429</ext-link></td><td valign="top">(1:20) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PE Mouse IgG2a, κ Isotype Ctrl, Clone MOPC-173 (Mouse monoclonal)</td><td valign="top">Biolegend</td><td valign="top">400213 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2800438">AB_2800438</ext-link></td><td valign="top">(1:20) FC</td></tr><tr><td valign="top">Antibody</td><td valign="top">PERK (D11A8) (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">5683S <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10841299">AB_10841299</ext-link></td><td valign="top">(1:200) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">Phospho-PERK (Thr980) (16F8) (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">3179S <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2095853">AB_2095853</ext-link></td><td valign="top">(1:100) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">IRE1α (14C10) (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">3294S <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_823545">AB_823545</ext-link></td><td valign="top">(1:200) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">eIF2α Antibody (FL-315) (Rabbit polyclonal)</td><td valign="top">Santa Cruz</td><td valign="top">sc-11386 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_640075">AB_640075</ext-link></td><td valign="top">(1:200) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">Phospho-eIF2α (Ser51) (Rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">9721S <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330951">AB_330951</ext-link></td><td valign="top">(1:100) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">Phospho-Lck (Tyr505) (Rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">2751 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330446">AB_330446</ext-link></td><td valign="top">(1:100) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">Phospho-Zap-70 (Tyr319)/Syk (Tyr352) (65E4) (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">2717 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2218658">AB_2218658</ext-link></td><td valign="top">(1:100) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">Zap-70 (D1C10E) XP (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">3165 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2218656">AB_2218656</ext-link></td><td valign="top">(1:200) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">CREB-2 (Rabbit polyclonal)</td><td valign="top">Santa Cruz</td><td valign="top">sc-200 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2058752">AB_2058752</ext-link></td><td valign="top">(1:200) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">BiP (C50B12) (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">3177 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2119845">AB_2119845</ext-link></td><td valign="top">(1:200) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-SEL1L (ab78298) (Rabbit polyclonal)</td><td valign="top">Abcam</td><td valign="top">ab78298 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2285813">AB_2285813</ext-link></td><td valign="top">(1:200) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">β-Actin (13E5) (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">4970S <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2223172">AB_2223172</ext-link></td><td valign="top">(1:1000) WB</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Notch 1 (ab27526) (Rabbit polyclonal)</td><td valign="top">Abcam</td><td valign="top">ab27526 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_471013">AB_471013</ext-link></td><td valign="top">(1:20) ChIP</td></tr><tr><td valign="top">Antibody</td><td valign="top">RBPSUH (D10A4) XP (Rabbit monoclonal)</td><td valign="top">Cell Signaling</td><td valign="top">5315 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2665555">AB_2665555</ext-link></td><td valign="top">(1:50) ChIP</td></tr><tr><td valign="top">Antibody</td><td valign="top">Normal Rabbit IgG (Rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">2729 s <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1031062">AB_1031062</ext-link></td><td valign="top">(1:250) ChIP</td></tr><tr><td valign="top">Antibody</td><td valign="top">Cleaved Caspase-3 (Asp175) (Rabbit polyclonal)</td><td valign="top">Cell Signaling</td><td valign="top">9661 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2341188">AB_2341188</ext-link></td><td valign="top">(1:50) IHC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>hCD2-iCre</italic></td><td valign="top">Jackson Laboratory Stock No. 008520</td><td valign="top">5' primer</td><td valign="top">AGATGCCAGGACATCAGGAACCTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>hCD2-iCre</italic></td><td valign="top">Jackson Laboratory Stock No. 008520</td><td valign="top">3' primer</td><td valign="top">ATCAGCCACACCAGACACAGAGATC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Vav1-iCre</italic></td><td valign="top">Jackson Laboratory Stock No. 008610</td><td valign="top">5' primer</td><td valign="top">AGATGCCAGGACATCAGGAACCTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Vav1-iCre</italic></td><td valign="top">Jackson Laboratory Stock No. 008610</td><td valign="top">3' primer</td><td valign="top">ATCAGCCACACCAGACACAGAGATC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Sel1l f/f</italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24453213">24453213</ext-link></td><td valign="top">5' primer</td><td valign="top">TTATGTCTGCTTAATTTCTGCTGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Sel1l f/f</italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18556558">18556558</ext-link></td><td valign="top">3' primer</td><td valign="top">TGAATGAGAAATCCAAGTAGTAGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Xbp1 f/f</italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18556558">18556558</ext-link></td><td valign="top">5' primer</td><td valign="top">ACTTGCACCAACACTTGCCATTTC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Xbp1 f/f</italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18556558">18556558</ext-link></td><td valign="top">3' primer</td><td valign="top">CAAGGTGGTTCACTGCCTGTAATG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Perk f/f</italic></td><td valign="top">Jackson Laboratory Stock No. 023066</td><td valign="top">5' primer</td><td valign="top">TTGCACTCTGGCTTTCACTC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Perk f/f</italic></td><td valign="top">Jackson Laboratory Stock No. 023066</td><td valign="top">3' primer</td><td valign="top">AGGAGGAAGGTGGAATTTGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Atf6 f/f</italic></td><td valign="top">Jackson Laboratory Stock No. 028253</td><td valign="top">Common Forward</td><td valign="top">TGCATCTGGGAAGAGAACCA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Atf6 f/f</italic></td><td valign="top">Jackson Laboratory Stock No. 028253</td><td valign="top">Wild type Reverse</td><td valign="top">TGCCATGAACTACCATGTCAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Atf6 f/f</italic></td><td valign="top">Jackson Laboratory Stock No. 028253</td><td valign="top">Mutant Reverse</td><td valign="top">AGACTGCCTTGGGAAAAGCG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>CD4-iCre</italic></td><td valign="top">Jackson Laboratory Stock No. 022071</td><td valign="top">Common Forward</td><td valign="top">GTT CTT TGT ATA TAT TGA ATG TTA GCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>CD4-iCre</italic></td><td valign="top">Jackson Laboratory Stock No. 022071</td><td valign="top">Wild type Reverse</td><td valign="top">TAT GCT CTA AGG ACA AGA ATT GAC A</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>CD4-iCre</italic></td><td valign="top">Jackson Laboratory Stock No. 022071</td><td valign="top">Mutant Reverse</td><td valign="top"><italic>CTT TGC AGA GGG CTA ACA GC</italic></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">OTII transgenic</td><td valign="top">Jackson Laboratory Stock No. 004194</td><td valign="top">Transgene Forward</td><td valign="top">GCT GCT GCA CAG ACC TAC T</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">OTII transgenic</td><td valign="top">Jackson Laboratory Stock No. 004194</td><td valign="top">Transgene Reverse</td><td valign="top"><italic>CAG CTC ACC TAA CAC GAG GA</italic></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Sel1l</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TGAATCACACCAAAGCCCTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Sel1l</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GCGTAGAGAAAGCCAAGACC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Xbp1</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CTGAGCCCGGAGGAGAAAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Xbp1</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CTTCCAAATCCACCACTTGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Xbp1s</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CTGAGTCCGCAGCAGGTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Xbp1s</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TCCAACTTGTCCAGAATGCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Ddit3(Chop)</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">GTCCCTAGCTTGGCTGACAGA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Ddit3(Chop)</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TGGAGAGCGAGGGCTTTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Erdj4</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CACAAATTAGCCATGAAGTACC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Erdj4</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TTTCATACGCTTCTGCAATCTC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Atf4</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CCACCATGGCGTATTAGAGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Atf4</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GTCCGTTACAGCAACACTGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Hrd1</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CAAGGTCCTGCTGTACATGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Hrd1</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GTGTTCATGTTGCGGATGGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Atf6</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">AGGGAGAGGTGTCTGTTTCG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Atf6</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CTGCATCAAAGTGCACATCA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>OS9</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">GGTGTCGGGAGCCTGAATTT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>OS9</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CCTCTCTTTCACGTTGGAAGTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Edem1</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">GGGGCATGTTCGTCTTCGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Edem1</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CGGCAGTAGATGGGGTTGAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Calreticulin</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CCTGCCATCTATTTCAAAGAGCA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Calreticulin</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GCATCTTGGCTTGTCTGCAA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Hyou1</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TGCGCTTCCAGATCAGTCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Hyou1</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GGAGTAGTTCAGAACCATGCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Canx</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">ATGGAAGGGAAGTGGTTACTGT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Canx</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GCTTTGTAGGTGACCTTTGGAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>GRP94</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TCGTCAGAGCTGATGATGAAGT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>GRP94</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GCGTTTAACCCATCCAACTGAAT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Hes1</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CCAGCCAGTGTCAACACGA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Hes1</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">AATGCCGGGAGCTATCTTTCT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Deltex</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">ATCAGTTCCGGCAAGACACAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Deltex</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CGATGAGAGGTCGAGCCAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>preTCRa</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TCACACTGCTGGTAGATGGA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>preTCRa</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TAGGCTCAGCCACAGTACCT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Notch1</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">ACACTGACCAACAAATGGAGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Notch1</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GTGCTGAGGCAAGGATTGGA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Actin</italic></td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TACCACCATGTACCCAGGCA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Actin</italic></td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CTCAGGAGGAGCAATGATCTTGAT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Vβ5 Forward</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">5' CCCAGCAGATTCTCAGTCCAACAG 3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Vβ8 Forward</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">5' GCATGGGCTGAGGCTGATCCATTA 3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Vβ11 Forward</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">5' TGCTGGTGTCATCCAAACACCTAG 3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Jβ2 Reverse</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">5' TGAGAGCTGTCTCCTACTATCGATT 3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">eF-la Forward</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">5'CTGCTGAGATGGGAAAGGGCT-3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">eF-la Reverse</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">5' TTCAGGATAATCACCTGAGCA 3'</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Sel1l promoter reporter wildtype</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TAGCACGCGTGGGAAATGACAAGCGGCATTGTCTTGTAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Sel1l promoter reporter wildtype</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">ATGCCTCGAGCCTGCTCTCGAAGGTCGAGAGCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Sel1l promoter reporter mutated left_arm</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CAGTTCAGGTATAGCTTATGGATCCGCGTTCATATCATGTCCAGTTCAAGGGATCCAAATAATTAAAAAGAAATACTTAGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Sel1l promoter reporter mutated left_arm</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GCTAAGTATTTCTTTTTAATTATTTGGATCCCTTGAACTGGACATGATATGAACGCGGATCCATAAGCTATACCTGAACTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Sel1l promoter reporter mutated right-arm</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TCTGGGCCAGGGAGGCCGTAAGGGGGGCGAAGAAGGAACC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Sel1l promoter reporter mutated right-arm</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TCTGGGCCAGGGAGGCCGTAAGGGGGGCGAAGAAGGAACC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter wildtype</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TAGCACGCGTGTGACCCCTGTGTAACGGTTTGATTCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter wildtype</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">ATGCAAGCTTGAAAACAGATATAGGTCTTCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter mutated left arm</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CCCCGGCCTATGGACTGCGCTGCATACGCTGGCATCCAGCTGCCTTGGCA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter mutated left arm</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TGCCAAGGCAGCTGGATGCCAGCGTATGCAGCGCAGTCCATAGGCCGGGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter mutated middle arm</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CCAGAAATTTTTCCTTTCTTGCATACTTGGTCCGCGTAACTTT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter mutated middle arm</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">AAAGTTACGCGGACCAAGTATGCAAGAAAGGAAAAATTTCTGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter mutated right arm</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TAGCACGCGTGTGACCCCTGTGTAACGGTTTGATTCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hrd1 promoter reporter mutated right arm</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">ATGCAAGCTTGAAAACAGATATAGGTCCCTTACGGTTACCTCCCCCCAAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Sel1l promoter P1</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TTCAGTTCAGGTATAGCTTATTTCTCAGCG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Sel1l promoter P1</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CGGTTAAGAACTTGCAAGGTTGCTAAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Sel1l promoter P2</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CCTTATGCCCTCAGCCACCTGCGGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Sel1l promoter P2</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GGGAACCCTCATCCAGGACTAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Sel1l promoter P3</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CGCTTAACAAGACAGCTGTTGGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Sel1l promoter P3</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TCTGGGGATTCAAATAACCATCTGGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Hrd1 promoter P1</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">GCTAGTTATGAATTGTAAGTAAACGTCTG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Hrd1 promoter P1</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CTGATTCTAGACGACTTTAAGGCAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Hrd1 promoter P2</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">AACCAATCGGCGGTAGCCACGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Hrd1 promoter P2</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GGATAGCTACGACACGGTAAGAAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Hrd1 promoter P3</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">TGCCCAGGTTTCACAGTGCAGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Hrd1 promoter P3</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">ACCGAGACGCAGGAGAACACC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Os9 promoter P1</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">GCTAGAGATGTCCCTTCCGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Os9 promoter P1</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">CAGCCAATGAAAGCTTGGGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Os9 promoter P2</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">GGAGGATAGCCGTGCTTTGA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Os9 promoter P2</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">ATCATAGCTAAGGAGTGAGAATGAG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Edem1 promoter P1</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CTACTCCATACCTGGACGGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Edem1 promoter P1</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">GCCCTAGCCCGGGTAAATG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Edem1 promoter P2</td><td valign="top">this paper</td><td valign="top">5' primer</td><td valign="top">CCCTGGTGAGTTGCTGATGT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">ChIP-qPCR, Edem1 promoter P2</td><td valign="top">this paper</td><td valign="top">3' primer</td><td valign="top">TGCTGTGAGTGTGTATGCGT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse Xbp1 splicing</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29480818">29480818</ext-link></td><td valign="top">5' primer</td><td valign="top">ACACGCTTGGGAATGGACAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse Xbp1 splicing</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29480818">29480818</ext-link></td><td valign="top">3' primer</td><td valign="top">CCATGGGAAGATGTTCTGGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Actin</italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29480818">29480818</ext-link></td><td valign="top">5' primer</td><td valign="top">TACCACCATGTACCCAGGCA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mouse <italic>Actin</italic></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29480818">29480818</ext-link></td><td valign="top">3' primer</td><td valign="top">CTCAGGAGGAGCAATGATCTTGAT</td></tr><tr><td valign="top">peptide, recombinant protein</td><td valign="top">Recombinant Murine Flt3-Ligand, 2 ug</td><td valign="top">250–31L</td><td valign="top">peprotech</td><td valign="top"/></tr><tr><td valign="top">peptide, recombinant protein</td><td valign="top">Recombinant Murine IL7, 2 ug</td><td valign="top">217–17</td><td valign="top">peprotech</td><td valign="top"/></tr><tr><td valign="top">peptide, recombinant protein</td><td valign="top">Recombinant Mouse DLL4</td><td valign="top">776702</td><td valign="top">Biolegend</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">High-Capacity cDNA Reverse Transcription Kit</td><td valign="top">4368813</td><td valign="top">Thermo Fisher</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Power SYBR Green PCR Master Mix</td><td valign="top">A25778</td><td valign="top">Thermo Fisher</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">In Situ Cell Death Detection Kit, Fluorescein</td><td valign="top">11684795910</td><td valign="top">Roche</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">FITC BrdU Flow Kit</td><td valign="top">559619</td><td valign="top">BD Bioscience</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">eBioscience Foxp3 / Transcription Factor Staining Buffer Set</td><td valign="top">00-5523-00</td><td valign="top">Thermo Fisher</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">ER-Tracker Green (BODIPY FL Glibenclamide), for live-cell imaging</td><td valign="top">E34251</td><td valign="top">Thermo Fisher</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">ProteoStat (R) Aggresome detect Kit</td><td valign="top">ENZ-51035-K100</td><td valign="top">ENZO</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Click-iT Plus OPP Alexa Fluor 647 Protein Synthesis Assay Kit</td><td valign="top">C10458</td><td valign="top">Thermo Fisher</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Genomic DNA Mini Kit</td><td valign="top">K182002</td><td valign="top">Thermo Fisher</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Truseq Stranded mRNA Kit</td><td valign="top"># 20020594</td><td valign="top">Illumina</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">DAPT</td><td valign="top">HY-13027</td><td valign="top">MedChemExpress</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">ISRIB (trans-isomer)</td><td valign="top">HY-12495</td><td valign="top">MedChemExpress</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Tunicamycin</td><td valign="top">76102–666</td><td valign="top">VWR</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Tetraphenylethene maleimide (TMI)</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31914399">31914399</ext-link></td><td valign="top">Custom Synthesized</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">STAR</td><td valign="top"/><td valign="top"/><td valign="top">Version 2.5.2b</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">DESeq2</td><td valign="top"/><td valign="top">R 3.6.1</td><td valign="top">Version 1.26.0</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">fgsea</td><td valign="top"/><td valign="top">R 3.6.1</td><td valign="top">Version 1.11.2</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">pheatmap</td><td valign="top"/><td valign="top">R 3.6.1</td><td valign="top">Version 1.0.12</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Enrichr</td><td valign="top"/><td valign="top"/><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://maayanlab.cloud/Enrichr/">https://maayanlab.cloud/Enrichr/</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Graphpad Prism 8.4</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://graphpad.com/">Graphpad (graphpad.com)</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Fiji</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://imagej.net/Fiji">http://imagej.net/Fiji</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">FlowJo 10</td><td valign="top">Tree Star</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008520">SCR_008520</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Biorender</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://biorender.com/">https://biorender.com/</ext-link></td><td valign="top"/><td valign="top">Biorender was utilized to make the schematic diagrams used in this study.</td></tr><tr><td valign="top">Other</td><td valign="top">LD Columns</td><td valign="top">130-042-901</td><td valign="top">Miltenyi Biotec</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">CD4 (L3T4) MicroBeads, mouse 1 x 2 mL</td><td valign="top">130-117-043</td><td valign="top">Miltenyi Biotec</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">CD8a (Ly-2) MicroBeads, mouse</td><td valign="top">130-117-044</td><td valign="top">Miltenyi Biotec</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride)</td><td valign="top">D1306</td><td valign="top">Thermo Fisher</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Precision Count Beads</td><td valign="top">424902</td><td valign="top">Biolegend</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">RBC Lysis Buffer (10X)</td><td valign="top">420301</td><td valign="top">Biolegend</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Liquid DAB+</td><td valign="top">K3468</td><td valign="top">Dako</td><td valign="top"/></tr></tbody></table></table-wrap></boxed-text></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69975.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name><role>Reviewing Editor</role><aff><institution>University of Toronto, Sunnybrook Research Institute</institution><country>Canada</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names> </name><role>Reviewer</role><aff><institution>University of Toronto, Sunnybrook Research Institute</institution><country>Canada</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Anderson</surname><given-names>Michele</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib><contrib contrib-type="reviewer"><name><surname>Wiest</surname><given-names>David</given-names> </name><role>Reviewer</role><aff><institution>Fox Chaser Cancer Center</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The findings by Liu and colleagues will be of interest to those working on T cell development, thymus biology and metabolic regulation of lymphocyte differentiation. The authors show that thymocytes undergoing pre-T cell receptor signaling, which leads to a highly proliferative state, require the endoplasmic reticulum-associated degradation (ERAD) complex to maintain high fidelity in their protein translational machinery, which enables thymocytes to effectively undergo further differentiation. Key components of the ERAD complex are shown to be under Notch regulation, further extending the absolute and critical role for Notch signaling in the differentiation of thymocytes.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Notch-Induced Endoplasmic Reticulum-Associated Degradation Governs Thymocyte b-Selection&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including JC Zúñiga-Pflücker as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen Satyajit Rath as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Michele Anderson (Reviewer #2); David Wiest (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) All three reviewers concurred with the importance and novelty of the work. No new experiments are required, and only clarifications or additional discussion points are required. Please see below for the specific points that need to be addressed.</p><p><italic>Reviewer #1:</italic></p><p>The work by Liu et al. addresses the translational activity associated with the β-selection step in T cell development, during which CD4- CD8- double negative (DN) thymocytes that have properly rearranged a T cell receptor (TCR) β chain undergo several quick rounds of cell division. The requirement for Notch and TCR-β, along with a pre-T-α chain to form the pre-TCR, have been understood for some time. However, whether Notch also regulated aspects of the translational activity in β-selection remained unknown.</p><p>Here the authors demonstrate that thymocyte differentiation from the DN to the CD4<sup>+</sup> CD8<sup>+</sup> double positive (DP) stage is tightly regulated by endoplasmic reticulum (ER)-associated degradation (ERAD) complex, which ensures proteome homeostasis, and key components of the ERAD are themselves under transcriptional regulation by Notch. These conclusions are solidly supported by several genetic approaches that take advantage of conditional knock-out mice for Sel1l, a key component of the ERAD complex.</p><p>The authors show that Sel1l deficient thymocytes fail to undergo efficient β-selection events and have increased ER stress and apoptosis via an unfolded protein response (UPR) activation of the PERK pathway. An elegant mixed bone marrow chimera approach is used to demonstrate the intrinsic requirement for Sel1l in allowing for effective β-selection.</p><p>The authors also reveal that the XBP1-dependent pathway play a redundant role during β-selection. Overall, the conclusions are strongly supported by the experimental approaches.</p><p>To increase the breath and potential impact of their findings the authors are encouraged to discuss whether a similar requirement for Sel1l would be present in T-ALLs that show a similar need for Notch signaling to maintain their proteostasis.</p><p>The work presented by the authors convincingly illustrates the role played by the ERAD complex in enabling β-selection induced proliferation and associated protein synthesis. The demonstration that Notch signaling directly regulates several of the key components of the ERAD complex, such as Sel1l1, nicely adds to our understanding of the critical role play by Notch at this stage of T cell development.</p><p>1) Given that Notch is also critically important for the survival and metabolism of many T-ALLs, it would be good for the authors to add this consideration in their discussion. This would further the impact of their work. Plus, if possible, they may be able to show that interfering with the Sel1l-HRD1 pathway can lead to T-ALL cell apoptosis.</p><p>2) It is not clear how the Dll4 signaling experiments were performed, was the Dll4 protein pre-bound to the plates prior to adding the EL4 cells? Otherwise, it is quite surprising to see a soluble Notch ligand being able to induce a productive Notch signal.</p><p>3) The dual loss of Sel1l and Xbp1 shows a very dramatic loss in thymus cellularity, perhaps this finding should be mentioned in the abstract.</p><p>4) In Figure 2 – supplement 2J, is there are reason that donor derived B cells were not shown?</p><p>5) The results shown in Figure 1 – supplement 1D-L, represent an enormous amount of work for the authors, even if the results from three additional conditionally-deleted gene mouse models are negative, they should be commended for their thoroughness.</p><p><italic>Reviewer #2:</italic></p><p>This manuscript describes a new type of quality control during the TCRbeta(b)-selection checkpoint of early T cell development. It is known that pre-TCR and Notch signaling at the DN3 to DN4 stages of thymocyte development results in a proliferative burst. High rates of protein translation during this rapid expansion can overwhelm the machinery required for proper protein folding, leading to endoplasmic reticulum (ER) stress. ER stress induces several pathways including the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway and the unfolded protein response (UPR) pathways. While these pathways have been well explored in plasma cell development, their roles in T cell development have been unclear. The importance of this question for understanding thymocyte biology is a major strength of the paper.</p><p>In this study, the authors conditionally deleted Sel1l, a central mediator of ERAD, in early T cell precursors using a CD2-Cre transgene. They found that thymocytes beyond the b-selection checkpoint were severely decreased, indicating a requirement for the ERAD pathway. Using a diverse set of complementary assays, they showed that the absence of Sel1l led to increased apoptosis of DN3 cells due to an increase in unfolded and misfolded proteins. This conclusion was robustly supported by separate assays measuring protein synthesis, ER stress, protein aggregation, proliferation, and apoptosis.</p><p>The defect in T cell development at the DN3 to DN4 transition was even more clearly manifested in a competitive bone marrow chimera study, emphasizing a cell intrinsic role for Sel1l in maintaining DN3 fitness.</p><p>By contrast, loss of Sel1l in the CD2-Cre mice did not affect gd T cell development, although the authors did not distinguish between different gd T cell subsets in this study. They also found that Sel1l was dispensable for T cell development after b-selection using a CD4-Cre transgene, which was consistent with the fact that positive selection of DP thymocytes does not result in a proliferative burst. The specific importance of the ERAD pathway was reinforced by studies of a number of mouse strains carrying mutations in the UPR responses, which did not perturb T cell development. The comprehensive nature of these analyses is a major strength of the paper.</p><p>Another important finding was that multiple members of the ERAD pathway were under direct regulation of Notch signaling in T lineage cells, providing a previously unappreciated role for Notch1 in regulating survival. Again, multiple complementary assays were used to reach this conclusion, including chromatin immunoprecipitation, promoter assays, and the use of OP9-DL4 cells to activate Notch signaling, which is a much more physiological method for studying Notch biology than introducing a constitutively activated form of Notch.</p><p>Interestingly, an RNA-seq analysis of Sell1l-deficient DN3 cells showed that genes belonging to UPR pathways were upregulated, presumably to help compensate for the absence of ERAD. Double mutants of Sel1l and Xbp1 exacerbated the defect, whereas deletion of PERK in Sel1l-deficient mice restored thymocyte numbers and survival. Thus, the authors concluded that Notch-mediated upregulation of the ERAD machinery alleviates the proteotoxic stress that occurs during the post-b selection expansion, and that PERK is required for the ER-stress cell death that occurs in the absence of ERAD.</p><p>This is a well-written, elegant, and comprehensive study that sheds new light on physiological parameters of T cell development. Moreover, the connection between Notch1 and ERAD highlights its central role in many aspects of survival at the b-selection checkpoint.</p><p>This is a comprehensive analysis of the pathways that regulate proteotoxic stress during T cell development, with well supported conclusions and beautifully presented data.</p><p><italic>Reviewer #3:</italic></p><p>The manuscript by Liu et al., explores the mechanisms controlling proteostasis during development of T cell progenitors in the thymus. Their principal finding is that the rapid transition from quiescence to active proliferation that occurs during traversal of the β-selection checkpoint causes the accumulation of misfolded proteins that are managed via dislocation from the endoplasmic reticulum (ER) into the cytol and degradation through the process of ER-associated degradation (ERAD). Moreover, the trophic signals that promote this transition and the capacity of these cells to manage their proteotoxic insult are both linked to Notch signaling and its capacity to induce genes associated with ERAD, specifically Sel1l. Sel1l appears to be a direct Notch target and its absence blocks traversal of the β-selection checkpoint via induction of proteotoxicity induced apoptosis. Apoptosis and the developmental arrest can be alleviated by co-elimination of one of the major ER-stress signaling effectors, PERK, but not another ER-stress effector XBP-1. Based on these findings, the authors conclude that Notch regulation of ERAD, but not ER-stress (or the unfolded protein response) play a critical role in supporting traversal of the β-selection checkpoint.</p><p>This study is well designed and executed, the experimental findings support the authors conclusions, and work performed provides new insight into a new role for Notch signaling in supporting the development of α-β lineage T cells.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69975.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>[…] To increase the breath and potential impact of their findings the authors are encouraged to discuss whether a similar requirement for Sel1l would be present in T-ALLs that show a similar need for Notch signaling to maintain their proteostasis.</p><p>The work presented by the authors convincingly illustrates the role played by the ERAD complex in enabling β-selection induced proliferation and associated protein synthesis. The demonstration that Notch signaling directly regulates several of the key components of the ERAD complex, such as Sel1l1, nicely adds to our understanding of the critical role play by Notch at this stage of T cell development.</p><p>1) Given that Notch is also critically important for the survival and metabolism of many T-ALLs, it would be good for the authors to add this consideration in their discussion. This would further the impact of their work. Plus, if possible, they may be able to show that interfering with the Sel1l-HRD1 pathway can lead to T-ALL cell apoptosis.</p></disp-quote><p>We thank the reviewer for raising this important point. We have now discussed the potential implication of ERAD in Notch-mediated T-ALLs in Discussion section as below:</p><p>“Activating NOTCH1 mutations are found in more than 50% of human T cell acute lymphoblastic leukemia (T-ALL) patients wherein Notch plays pivotal roles in regulating the survival and metabolism of T-ALL cells. It will be of interest in future studies to investigate whether Notch-regulated ERAD also promotes ER proteostasis and sustains T-ALL survival by clearing misfolded proteins and restricting ER stress-induced cell death&quot;.</p><disp-quote content-type="editor-comment"><p>2) It is not clear how the Dll4 signaling experiments were performed, was the Dll4 protein pre-bound to the plates prior to adding the EL4 cells? Otherwise, it is quite surprising to see a soluble Notch ligand being able to induce a productive Notch signal.</p></disp-quote><p>For Figure 4C, DLL4 was pre-bound to the plates prior to adding the EL4 cells. For Figure 4B, F-I, K, and L, soluble DLL4 (5mg/ml) was used. We agree with the reviewer that pre-bound Notch ligands tether the Notch extracellular domain away from the NICD. However, other studies also show that 0 Notch ligands can induce a productive Notch signal as well (PMID: 22869002; PMID: 8575327; PMID: 12370358)<sup>1–3</sup>. In PMID:22869002<sup>1</sup>, both anchored and soluble DLL4 induced HES<sup>-1</sup> and Notch cleavage of the intracellular domain significantly in macrophages. We used exactly the same DLL4 and our data show that it effectively induced classical Notch target genes <italic>Hes1</italic>, <italic>Deltex1</italic> and <italic>Ptcra</italic> (Figure 4—figure supplement 1A). We have clarified the technical details in Materials and methods.</p><disp-quote content-type="editor-comment"><p>3) The dual loss of Sel1l and Xbp1 shows a very dramatic loss in thymus cellularity, perhaps this finding should be mentioned in the abstract.</p></disp-quote><p>We appreciate the reviewer’s kind suggestion. We have now mentioned this finding in the Abstract as below:</p><p>“In contrast, IRE1a/XBP1 pathway was induced as a compensatory adaptation to alleviate <italic>Sel1l</italic>-deficiency induced ER stress. Dual loss of <italic>Sel1l</italic> and <italic>Xbp1</italic> markedly exacerbated the thymic defect”.</p><disp-quote content-type="editor-comment"><p>4) In Figure 2 – supplement 2J, is there are reason that donor derived B cells were not shown?</p></disp-quote><p>We thank the reviewer for the questions and have now included donor derived B cells data in Figure 2-supplement 2J. <italic>hCD2-iCre</italic> efficiently induces gene deletion in B cells (PMID: 12548562)<sup>4</sup>. Consistent with previous publications showing that SEL1L/HRD1 ERAD is required for B cell development through regulating pre-BCR (PMID: 27568564 and 29907570)<sup>5,6</sup>, our <italic>hCD2-iCre</italic> mediated <italic>Sel1l</italic> deletion also caused significant B cell reconstitution defects in the recipient mice. We have included the data and description in the manuscript.</p><disp-quote content-type="editor-comment"><p>5) The results shown in Figure 1 – supplement 1D-L, represent an enormous amount of work for the authors, even if the results from three additional conditionally-deleted gene mouse models are negative, they should be commended for their thoroughness.</p></disp-quote><p>We appreciate the reviewer’s kind comments on our data from multiple UPR conditional knockout mouse models.</p><p>References:</p><p>1. Camelo, S. et al. Δ-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages. Angiogenesis 15, 609–622 (2012).</p><p>2. Fitzgerald, K. and Greenwald, I. Interchangeability of <italic>Caenorhabditis elegans</italic> DSL proteins and intrinsic signalling activity of their extracellular domains in vivo. Dev Camb Engl 121, 4275–82 (1995).</p><p>3. Weijzen, S. et al. The Notch Ligand Jagged-1 Is Able to Induce Maturation of Monocyte-Derived Human Dendritic Cells. J Immunol 169, 4273–4278 (2002).</p><p>4. Boer, J. de et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 33, 314–325 (2003).</p><p>5. Ji, Y. et al. The Sel1L-Hrd1 Endoplasmic Reticulum-Associated Degradation Complex Manages a Key Checkpoint in B Cell Development. Cell Reports 16, 2630–2640 (2016).</p><p>6. Yang, Y. et al. The endoplasmic reticulum–resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice. J Biol Chem 293, 12934–12944 (2018).</p></body></sub-article></article>